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ABSTRACT 
This study was carried out to determine the prevalence of lymphogranuloma venereum 
(LGY) amongst patients with genital ulcer disease (GUD); to evaluate available methods 
for the diagnosis of LGY; and to serotype chlamydia! isolates from genital ulcers. An 
attempt was also made to correlate urethral infection with isolation from genital ulcers 
using Ligase chain reaction (LCR) and direct immunofluorescence (DIF) tests. 
Genital ulcer specimens were inoculated onto McCoy cells and the culture-positive 
specimens immunotyped by the rnicroimmunofluorescence (MIF) test. DNA was extracted 
from McCoy cells of the culture negative and positive specimens, was subjected to 
specific amplification of the Chlamydia trachomatis cryptic plasmid gene by PCR. 
Specific amplification of the major outer membrane protein (MOMP) gene by PCR, was 
carried out on all samples in which the 452 bp product of the plasmid gene was detected. 
First void urine (FVU) specimens and endourethral swab specimens collected for the 
diagnosis of concurrent urethral infection, were subjected to a plasmid based LCR and 
examined for the presence of chlamydia! antigen by direct immunofluorescence (DJF) test, 
respective! y. 
LGV infection was detected by culture in 13 (5.3 %) of the 247 patients studied. Using the 
MIF test, 5 LGV strains (LI = I, L2 =4) and 4 oculogenital strains (Ia =2, E=2) were 
detected. The remaining 4 could not be typed as viability is required for immunotyping 
and these were not recoverable. PCR for the specific amplification of the plasmid gene 
detected 22.3% (55/247) of the infections, inclusive of the 13 samples that were positive 
by culture and an additional 42 that were negative by culture. The specific amplification 
of the MOMP gene by PCR was less sensitive and detected 26/55 (47.3%) infections 
detected by the former. In urethral specimens, LCR detected 46/247 (18.6%) of the 
chlamydia! infections while DIF detected 36/230 (15.6%). Of the 54 patients that had 
urethral infection, 44.4 % were found to have chlamydial infection of their ulcers. Of the 
II 
193 patients who did not have chlamydia! infection in the urethra, 16.1 % had C. 
trachomatis isolated from their ulcer specimens. The association of chlamydial infection 
found in the urethra or in the ulcers was found to be significant (p=0.001) with a relative 
risk of 2.75. 
Using the expanded gold standard for the diagnosis of chlamydia! infection, this study 
showed a high prevalence of infection in ulcers (22.3%). The isolation of oculogenital 
strains from genital ulcer specimens suggests that in addition to the L strains, LGV may 
be caused by non LGV strains. Since more than one GUO causing pathogens were 
isolated from several ulcers, contamination by the oculogenital strains remains a 
possibility. As far as chlamydia! diagnosis of genital ulcers is concerned, specific 
amplification of plasmid DNA by PCR (despite its inability to differentiate between the 
oculogenital and the LGV serotypes) is the method of choice, above culture alone. 
However, further investigations on the significance of the oculogenital strains in the 
pathogenesis of ulcer disease are required. 
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In this research the statistical planning and analyses, and 
recommendations arising from these analyses have been done in 
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Chlamydiae are a group of obligate intracellular bacteria that cause a variety of clinical 
syndromes in humans, other mammals, and birds. Until recently, they were considered 
to be viruses because of their small size and the difficulty associated with their isolation, 
particularly since they cannot be grown on synthetic media. Neisseria gonorrhoeae was 
once considered to cause the most prevalent sexually transmitted disease (STD) in both 
the developed and undeveloping countries. In South Africa, studies conducted from 1979 
to 1991, show that 64 96 % of urethritis cases were gonococcal in aetiology (Pham-Kanter 
et al, 1996). However, in the last two decades, Chlamydia trachomatis has been 
recognized as a major world health problem not only as the causative agent of trachoma, 
but also as one of the most common bacterial STDs. In the United States alone, C. 
trachomatis is reported to have an annual incidence of greater than 4 million infections, 
with the direct and indirect costs exceeding $2.4 billion. 
C. trachomatis comprises 18 established serotypes, four of which (LI, L2, L2a, L3)
produce lymphogranuloma venereum (LGV), an ulcerative condition associated with 
lymphadenopathy of the inguinal region. Four serotypes namely (viz.) A, B, Ba, and C, 
cause trachoma, a chronic inflammatory disease which may lead to conjunctiva[ and 
corneal scarring. Trachoma is the most common cause of preventable blindness in the 
world today (Darougar and Jones, 1983; De Sole, 1987; Bailey et al, 1989; Piot and Laga, 
1989; Loewenthal and Pe'er, 1990). The remaining ten serotypes (D to K) are responsible 
for causing urethritis, epididymitis, cervicitis, pelvic inflammatory disease (PIO), and 
endometritis complicated by infertility and ectopic pregnancy; they also cause reactive 
arthritis, ophthalmia neonatorum and infantile pneumonia (Beem and Saxon, 1977; 
Viswalingam, 1983; Kiviat, et al, 1990; Stanley et al, 1990; Eley et al, 1992; Sands, 
1992). The diseases are referred to as oculogenital infections. 
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Recent studies at various centres in South Africa, have shown that chlamydia! infections 
are on the increase with prevalence rates of 18 34 % (Ballard et al, 1986; Hoosen et al, 
1993; O'Farell et al, 1994). Co infections of C. trachomatis and Neisseria gonorrhoeae 
are also very common. These account for 44-95 % of cases where C. trachomatis is 
detected, while its presence in genital ulcer cases ranges between 7 % and 12 % (Pham­
Kanter et al, 1996). Syphilis and chancroid have been reported to be the two most 
common types of sexually transmitted genital ulcer diseases (GUO), with LGV accounting 
for only 1-7% of GUO in South Africa (Crewe-Brown et al, 1982; Coovadia et al, 1985; 
O'Farell et al, 1991; O'Farell et al, 1994). However, this percentage range is not a true 
reflection of the frequency of LGV in South Africa, as this ulcerative condition is highly 
prevalent in some distinct rural and urban regions of the subcontinent such as Kwazulu­
Natal, Mpumalanga (previously known as Eastern Transvaal), and Transkei (Pham Kanter 
et al, 1996). Since most centres do not have laboratory facilities which are competent 
enough to concisely diagnose LGV, underdiagnosis can be expected. 
Studies conducted in other parts of Africa like the Gambia, Ethiopia, Kenya, Nigeria, and 
Zimbabwe, still rank syphilis and chancroid as the most prevalent GUO, and reported 
LGV to be a minor contributor to GUO with a prevalence of between 0.55 % to 8 % 
(Nsanze et al, 1981; Mabey et al, 1987; Duncan et al, 1992; Ghatak, 1992; Tswana et al, 
1995). However, in one study done in Madagascar, LGV was the second most common 
GUO isolated with a prevalence of 24%; syphilis was still the most common at 46%, and 
chancroid third at 16% (Harms et al, 1994). 
LGV is a chronic disease with a variety of acute and late manifestations and a three stage 
clinical course (Van Dyck and Piot, 1992). It's primary stage, is manifested as a small, 
painless genital papule or shallow ulcer of short duration with few symptoms. The most 
common is the secondary stage characterized by acute inguinal lymphadenitis with bubo 
formation (inguinal syndrome) and/or acute haemorrhagic proctitis (the anogenitorectal 
syndrome), together with fever and other symptoms due to the systemic spread of the 
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infection. Should chlamydia persist, late complications may occur in the anogenital tissue 
such as ulcers, fistulae and strictures (Schachter and Osoba, 1983; Perine and Osoba, 
1984; Piot and Laga, 1989; Van Dyck and Piot, 1992; Chopda et al, 1994). In patients 
who are seropositive for the human immunodeficiency virus (HIV), latent LGV may be 
reactivated with the development of multiple abscesses in the groins (Latif, 1990; Martin, 
1990). At this stage, the response to antichlamydial drugs is poor, and the destruction of 
inguinal lymphnodes often results in lymphoedema of the genitalia, a chronic condition 
with persisting suppuration and pyoderma (Greenblatt, 1989). 
The increase in chlamydia! infections can be attributed to lack of diagnostic facilities and 
lack of appropriate therapy which leads to continued spread. Undetected infection puts the 
infected person at risk for serious long term sequelae and sustains transmission within a 
community. Since symptoms are often mild or absent in the majority of the infected 
patients, diagnostic testing is the only way to detect infection. Therefore, screening of 
populations at risk for infection (especially those attending STD clinics), must be a part 
of STD control and prevention strategies. 
The laboratory diagnosis of LGV is usually based on (1) positive chlamydia! serology, (2) 
isolation of C. trachomatis from the infected site(s) and/or (3) histological identification 
of chlamydia in infected tissue (Lefebre et al, 1988; Ridgway and Taylor-Robinson, 1991; 
Taylor Robinson and Thomas, 1991; Centers for Disease Control and Prevention -CDC, 
1993). These methods include different staining procedures to demonstrate intracellular 
inclusion bodies, direct detection of C. trachomatis antigens by fluoresceine labelled 
monoclonal antibodies or by enzyme immunoassay (Tarn et al, 1984; Stamm and Mardh, 
1990; Ridgway and Taylor-Robinson, 1991; Young et al, 1991). Although these tests are 
rapid and simple to perform, none of them show optimal sensitivity and accuracy which 
is an ongoing quest of chlamydia) research. Cell culture is the most sensitive and specific 
method for diagnosis of C. trachomatis and although it is laborious, costly, and requires 
cell culture facilities unavailable in many laboratories, it still remains the gold standard 
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(Lefebre et aL, 1988; Taylor-Robinson, 1991). 
With advances in technology with molecular techniques such as polymerase chain reaction 
(PCR) and ligase chain reaction (LCR), cell culture is no longer being used routinely and 
large volumes of specimens are now being processed in shorter time and at a low cost 
(Kellogg, 1989; Claas et aL, 1990; Ostergaard et aL, 1990; Frost et al, 1993; Chernesky 
et aL, 1994; Bassiri et aL, 1995; Lee et al, 1995). Although these assays (PCR, LCR) 
have higher sensitivities than cell culture or enzyme immnoassays (EIA) due to their ability 
to detect even the smallest amounts of specific nucleic acid, they also have limitations in 
that, they cannot differentiate between strains causing LGV and oculogenital infections. 
This study proposes to determine the prevalence of LGV amongst patients with genital 
ulcer disease attending the STD Clinic in Durban; to evaluate available methods for the 
diagnosis of LGV including an analysis of molecular techniques such as LCR and PCR, 
and serotype chlamydia! isolates from genital ulcers. 
CHAPTER2 
REVIEW OF LITERATURE 
2.1 IIlSTORICAL PERSPECTIVE OF CHLAMYDIAE 
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In the past, the Chlamydia organisms were referred to as: Bedsonia, 
Psittacosis/Lymphogranuloma venereum/Trachoma (PLT) causing agents, Miyagawanella 
and trachoma/inclusion conjunctivitis (TRIC) agents. Due to their unique developmental 
cycle, they have now been placed in a separate order, Chlamydia/es, with one family, 
Chlamydiaceae, containing one genus, Chlamydia with four species viz. C. trachomatis, 
C. psittaci, C. pneumoniae and C. pecorum (Page, 1968; Fukushi et al, 1992).
Trachoma -a blinding eye disease- is one of the oldest recognized human chlamydia! 
diseases having been described in the Ebers papyrus (1500 BC). It has long been known 
to the ancient Greeks and Romans before its causative agent C. trachomatis was 
discovered. The name is also Greek - rpoawµOl meaning roughness, and refers to the 
characteristic conjunctiva! follicles (Collier and Ridgway, 1989). Common in the Middle 
East and sub-Saharan Africa, trachoma is believed to have been disseminated to Europe 
by soldiers returning from military campaigns. [t was estimated by the World Health 
Organization in 1973, that 400 million people had trachoma with blindness occurring in 
2 million (Tarizzo, 1973). 
Non-gonococcal urethritis (NGU), was described only after Albert Neisser discovered the 
gonococcus in 1879 (Neisser, 1879; Cited by Goh and Forster, 1993). Initially in the 18th 
century, Gonorrhoea virulenta and Gonorrhoea simplex were considered as two entities 
with the latter being a milder condition, the urethral discharge being mucoid rather than 
purulent and also having unusual complications. It was when many cases of acute 
urethritis showed no evidence of gonococci that urethritis non gonorrhoica was described. 
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The aetiology of ophthalmia neonatorum was also poorly understood, though it was known 
that a connection existed between ophthalmia neonatorum and maternal leucorrhoea. Only 
when some babies with a milder form of ophthalmia presented with no signs of the usual 
blinding potential of gonococcal ophthalmia, was conjuctivite amicrobienne described by 
Kroner, in 1884 (Kroner, 1884). The adult syndrome now known as inclusion 
conjuctivitis, was at that time less well recognized, though it was hypothesised that the eye 
infection could have been due to contact with non-gonococcal genital discharges. 
The invasive biovar of C. trachomatis, lymphogranuloma venereum (LGV), which causes 
the systemic sexually transmitted disease, was described for the first time, as a suppurative 
inguinal bubo by John Hunter, in 1786. He thought that it could not be syphilitic, but 
might be "scrofulous". Similar cases were apparently, also reported in 1833 by the Irish 
surgeon William Wallace who recorded fistula formation and by the French venereologist 
Phillipe Ricord in 1867 who described it as "bubo d'embI'ee". However, it was not until 
1913 that Durand, Nicolas and Favre established the disease as a clinical and pathological 
entity (Favre and Hellerstrom, 1954). They called it Lymphogranuloma inguinale, together 
with various names (cited: Perine and Osoba, 1984) until eventually, settling for 
Lymphogranuloma venereum (LGV). 
Combinations of vulva! elephantiasis with or without ulceration (esthiomene) and rectal 
strictures known as the "genito-anal rectal syndrome", which is a late complication of 
LGV, had been known since the middle of the 19th century, despite the uncertainty 
surrounding its cause. This disease did not become established as a chlamydia! disease 
until the 1940s, although its diagnosis had been facilitated by the delayed hypersensitivity 
test introduced by Wilhelm Frei in 1925; he later managed to show that the "genito ano­
rectal syndrome" was linked to LGV. The first LGV case report on prepubertal children 
was reported in 1925 by Weiss and Cain; it involved a 14 year old girl presenting with 
suppurative inguinal bubo (Weiss and Cain, 1925). However, it was not until 1957 that 
T'ang et al in Peking, succeeded in growing C. trachomatis into the yolk of embryonated 
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hen's eggs (T'ang et al, 1957) and this provided additional proof that LGV and other 
chlamydia} diseases were all caused by a similar agent. 
The causative agent, Chlamydia trachomatis was first observed in stained conjunctiva! 
scrapings by Ludwig Halberstaedter (a dermatologist) and Stanislaus von Prowazek (a 
microbiologist) in 1907 (Halberstaedter and Prowazek, 1909; Becker, 1978; Jones 1983). 
The diagnostic intracytoplasmic inclusions were recognized first experimentally, in 
specimens from subhuman primates infected with human trachomatous material. Jn 1910, 
Lindner et al, described epithelial inclusions in the cervix of the mother of a neonate with 
atypical inclusion conjunctivitis or "inclusion blennorrhoea" (cited: Jones, 1983). 
However, the first isolation of C. trachomatis from a neonate with non gonococcal 
ophthalmia and from the cervix of the mother of another such infant, were reported by 
Jones, Collier and Smith (1959). Lindner, as well as Heyman and Stargardt (Jones, 1983; 
Cassell et al, 1982), proceeded to demonstrate epithelial inclusions in the cervix of a 
woman whose partner had an inclusion positive NGU. Halberstaedter and von Prowazek 
called the newly discovered organisms Chlamydozoa (Greek X n AMUE, a mantle), 
because of the blue staining matrix in which the elementary bodies are embedded. These 
discoveries laid the clinical and epidemiological groundwork for understanding oculogenital 
chlamydia) infection. 
Chlamydia researchers found themselves at a dead end due to lack of a sensitive and 
specific laboratory diagnostic technique especially when the yolk sac method turned out 
to be good but unsuitable for screening large numbers of specimens. The method is time
consuming and labour-intensive, and the necessity to grow chlamydia within cells as for 
viruses, has precluded many bacteriological and genetical approaches. A breakthrough 
only came in 1965, when Gordon and Quan introduced cell culture techniques for C. 
trachomatis isolation (Gordon and Quan, 1965; Gordon et al, 1969). It was also 
discovered that, by inhibiting the replication of cells, favours C. trachomatis in its 
competition for ATP with host cells. Methods improved and years later, in 1970, Wang 
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and Grayston introduced the microimmunofluorescent (Micro IF) test for the detection of 
antibody and for immunotyping (Wang and Grayston, 1970). These developments led to 
the elucidation of the wide spectrum of this organism especially in the confirmation of the 
etiologic role of C. trachomatis in NGU. 
Psittacosis (Parrot fever), caused by C. psittaci, was first described by Ritter (1879) in 
Switzerland when several cases of unusual pneumonia associated with exposure to tropical 
birds began to surface (Schaffner, 1990). In 1894, Morange in Paris, investigated an 
outbreak and concluded that parrots were the source of infection. He named the illness 
after the Greek word for that bird, psittakos. According to Meyer (cited: Meyer, 1942), 
a pandemic resulted between 1929 and 1930, after large scale importation of infected South 
American birds to Europe and the United States. In 1930, Bedson managed to isolate the 
filterable agent from human and avian tissues while Rivers and colleagues, studied the 
infection in laboratory animals which led to the conclusion that the prohable route of 
human infection is by the upper respiratory tract due to the inhalation of dried excreta of 
birds shedding the agent. 
The designation of the TWAR strain, currently known as C. pneumoniae, was derived 
from laboratory codes of the first two isolates viz. TW 183, isolated in 1965 (during 
Trachoma studies in Iran and Taiwan) from conjunctiva! swabs, and AR 39, which was 
isolated in 1983, in Seattle, United States, from the pharynx of a college student with an 
upper respiratory infection (Grayston et al, 1986; Grayston et al, 1989a; Grayston et al, 
1990). Another atypical strain (strain IOL 207) was isolated in the 1970s, at the Institute 
of Ophthalmology (London), from an Iranian child with Trachoma (Forsey et al, 1986). 
TWAR was initially considered as a subspecies of C. psittaci but subsequent analyses have 
demonstrated that this organism is distinct from both C. psittaci and C. trachomatis. 
TW AR is now recognized as the third species of Chlamydia (Grayston et al, 1989a). Like 
C. trachomatis, its strains appear to be circulating among humans without an avian
reservoir. 
2.2 GENERAL CHARACTERISTICS OF THE GENUS CHLAMYDIA 
9 
The Chlamydiae are small, coccoid, non-motile, gram-negative bacteria which are obligate, 
intracellular parasites. The special combination of viral and bacterial properties that 
characterize Chlamydia has led to both taxonomic and terminologic confusion. Long 
classified as large viruses due to their size (200-400 nm in diameter) and their intracellular 
parasitism (Schachter and Dawson, 1979; Ward, 1983), Chlamydia organisms are now 
considered as a special type of bacteria. They differ from viruses by possessing both DNA 
and RNA, have cell walls analogous to gram-negative bacteria, are susceptible to 
antibiotics, possess a number of enzymes, divide by binary fission inside host cells, and 
contain ribosomes. They cannot synthesize ATP and are therefore considered as energy 
parasites (Moulder, 1984; Cook and Honeybourne, 1994). Neither muramic acid nor a 
peptidoglycan layer are present in Chlamydia cell walls (Caldwell et al, 1981). The 
structural rigidity of the cells is caused by a n-acetyl glucosamine polypeptide layer, for 
which construction penicillin-binding proteins are used (Barbour et al, 1982). These are 
similar in location (inner membrane), size, and affinity for the antibiotic to those of 
bacteria with peptidoglycan in the cell wall (Matsumuto and Manire, 1970). 
C. trachomatis consists of three biovars: the trachoma (caused by serotypes A, B, Ba and
C), LGV (caused by Ll, L2 and L3 serovars), and murine (mouse pneumonitis) biovar. 
The trachoma biovar also includes serotypes D through K which are responsible for human 
oculo-genital diseases (Table I). C. psittaci which is primarily an animal pathogen, causes 
atypical pneumonia (Borg) and endocarditis in man. It consists of +I 120 strains which 
include 6C (parakeet), psittacosis meningopneumonitis (Cal 10), bovine (EBA-59-795) and 
ovine chlamydia! abortion, feline and ovine pneumonitis, bovine encephalomyelitis, 
epizootic chlamydiosis, pigeon and turkey ornithosis, and sheep polyarthritis (Becker, 
1978; Cassell et al, 1982; Barnes, 1989). The newly recognized species C. pneumoniae 
(TWAR strain), causes human respiratory disease (Grayston et al, 1993) and has drawn 
much attention due to difficulties involved in its diagnosis. C. pecorum on the other hand, 
is reported to cause diseases such as encephalomyelitis, polyarthritis, pneumoniae, and 
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enteritis in cattle and sheep. C. pecorum type strain is strain Bo/E58 (=ATCC VR628), 
which was isolated in 1953 from the brain of a calf that had sporadic bovine 
encephalomyelitis. The isolated organism was subsequently identified as a member of the 
genus Chlamydia (Wenner et al, 1953). Other reports available on this species, involve 
information on monoclonal antibodies used for micro-immunofluorescence typing for its 
serovars, together with those of other Chlamydia species (Fukushi et al, 1992; Kuroda­
Kitagawa et al, 1993). 
C. trachomatis strains are sensitive to sulphonamides, produce a single round inclusion that
displaces the nucleus of host cell, and also stains with iodine due to the presence of 
glycogen. C. psittaci and strains are resistant to sulphonamides, produce glycogen­
negative inclusions that rupture early distributing themselves around the host cell nucleus 
without displacing it (Collier, 1989). C. pneumoniae has less than 10% DNA homology 
with the other species, produce glycogen-negative inclusions with typically pear-shaped 
elementary bodies. C. pneumoniae strains are also immunologically distinct, lacking cross 
reactivity when exposed to monoclonal antibodies to strains of Chlamydia (Campbell et al, 
1987). Table I shows some characteristics of Chlamydia species. 
2.3 CELL MORPHOLOGY AND DEVELOPMENTAL CYCLE 
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The interaction of Chlamydiae with the host is complex, parasitic and most often, results 
in cell destruction. Chlamydiae are highly pleomorphic and share a general sequence of 
events in their reproduction. They exist in two distinct forms: the infectious, non dividing 
elementary body (EB) which is a "spore like" structure adapted for extracellular survival 
and transit between host cells, and the non infectious reticulate body (RB) or the "initial 
body" that divides intracellularly by binary fission (Pearlman and McNeeley, 1992; 
Mathews et al, 1993). The EBs are spherical cocci of about 300-400 nm in diameter; they 
contain electron dense nuclear material with numerous ribosomes surrounded by a rigid 
trilaminar wall. The RBs are larger forms of 800 1000 nm in diameter, have less dense, 
fibrillar nuclear material, more ribosomes and non rigid trilaminar walls (Becker, 1978; 
Moulder, 1991). 
The developmental cycle begins with the infection of the susceptible host cell by the EB, 
through sexual contact or direct exchange of body fluid (Dunlop et al, 1972; Schachter et 
al, 1975; Grayston et al, 1985). Evidence suggests the involvement of the chlamydia! 
adhesins in promoting chlamydia! attachment and of the host receptor, in promoting 
chlamydial adhesion. After attachment at a specific site, the EB enters the host cell inside 
a phagosome. Chlamydia do not enter the cytoplasm of the host cell, but remain and 
multiply within the phagocytic vacuole which is somehow protected from fusion with 
lysosomes (Bowie and Holmes, 1990; Zhang and Stephens, 1992), and which eventually 
expands to fill much of the cytoplasmic volume of the cell. The rate of attachment and 
phagocytosis depends on both the infecting strain and the mode of presentation to the host 
cell (Ward and Clarke, 1990). 
The reproductive cycle usually takes 30-48 h, but can take as long as 96 h in a less 
hospitable atmosphere. During the first 6 8 h after infection, the EB reorganizes into RB. 
Then approximately 8-10 h after infection, RB starts to divide by binary fission within the 
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membrane-bound vacuole. From 10 20 h post infection, RBs can be found at various 
stages of division viz. EBs, intermediate forms and RBs. At 18-24 h after infection, while 
the RBs continue to divide and to reorganize, the size of the individual bodies diminishes 
and the RBs reorganize themselves into large numbers of EBs by a poorly understood 
reorganization or condensation process. Towards the end of the cycle, an inclusion may 
contain hundreds of EBs filling almost the entire cytoplasm of the host cell. Thus, 
approximately 48-72 h post infection, depending on the strain, the mature infectious EBs 
are released from the host cell by a phenomenon similar to exocytosis (Todd and Caldwell, 
1985) to initiate another cycle of infection. Due to high multiplicity and large size of the 
inclusions, the host cell may burst and die (Moulder, 1991). The yield of EBs per host 
cell varies from 10 to 1000, depending again on both the chlamydia! strain and the host 
cell and among other factors, the culture conditions. Figure 1, illustrates the development 
cycle of the Chlamydiae. 

2.4 MOLECULAR BIOLOGY OF CHLAMYDIAE 
2.4.1 Genetics 
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The Chlamydiae have relatively small genomes compared to other prokaryotes. 
The genome of C. trachomatis is composed of circular double-stranded 
deoxyribonucleic acid (DNA) with a molecular weight (M,) of approx. 6.6 X 108
daltons (11 X 105 nucleotide pairs) (Becker, 1978; Moulder, 1984a). The Guanine­
plus-cytosine content (mol % G+C) of the DNA is 42.5 % (Tm). This mol % G+C 
composition is determined by thermal denaturation of the DNA of a number of 
chlamydial strains and has been found to range from 41 to 44 mol % , with C. 
psittaci strains at the lower end of a continuous spectrum of values while C. 
trachomatis biovar trachoma strains are at the higher end (Moulder et aL, 1984b). 
Tm is the melting temperature of DNA at which absorbance A260 is half complete. 
This Tm, increases with every increase in percentage Guanine+cytosine (% G+C) 
due to the relative number of hydrogen bonds in G+C as compared to Thymine 
and Adenine (A+T) pairs (Freifelder, 1986). 
Data derived from DNA homology studies have shown that of the presently 
recognized four species, only the most recently acknowledged member, C. 
pneumoniae, is a single species having 60-70 % DNA/DNA homology (Storey et 
aL, 1993). Only 10-30% DNA relatedness has been found between C.trachomatis 
and C. psittaci by the thermostability test, which is a thermal denaturation 
measurement (Kingsbury and Weiss, 1968; Moulder, 1991). Storey et aL (1993), 
described the characterization and taxonomic status of Nl6, a C. pneumoniae strain 
isolated from the respiratory tract of a horse. This strain of equine origin, shows 
94.5% and 94.4% DNA homology with TWAR isolates IOL-207 and AR-39 
respectively, and 70.9% to 71.1 % homology with C. pecorum. Thus, DNA 
homology and monoclonal antibody data from this study, suggest that horse 
Chlamydiae, as exemplified by Nl6, form a new second biovar of C. pneumoniae. 
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However, the intraspecies homology among strains of Chlamydia is near 100%, 
even though the mouse pneumonitis biovar (MoPn) of C. trachomatis displays 30
70 % homology to other human strains of that species (Weiss et al, 1970; Moulder 
et al, 1984a; Moulder et al, 1984b). There is complete DNA homology between 
the trachoma and LGV biovars in all strains tested. 
Electron micrographs of chlamydiae inside host cells show that RBs have many 
more ribosomes than EBs do. The EB has equal DNA and RNA content whereas 
RB contains three to four times more RNA than DNA. The Chlamydiae also 
contain 23S, 16S, and 5S ribosomal RNA (rRNA) as 50S and 30S subunits. The 
16S rRNA sequences of C. trachomatis LGV Biovar, C. pneumoniae 6BC strain 
and C. psittaci strains differ by 5 % (thus exhibiting greater than 94 % homology) 
and have been found to be extremely different from the sequences (l 6S rRNA) of 
the other known eubacteria (Cox et al, 1988; Gaydos et al, 1993). C. trachomatis 
also has two rRNA operons that differ from other prokaryotes (Engel and Ganem, 
1987). 
Plasmids of 4.4 X 106 daltons (7.5 kilobases kb) has been described (Peterson and 
de la Maza, 1983). These plasmids were first identified in Chlamydia in 1980 by 
Lovett et al, and it was originally believed that all chlamydia) isolates possessed 
a plasmid but, according to Campbell et al (1987) and McClenagan et al (1988), 
certain types of C. psittaci and C. pneumoniae, lack this plasmid. C. pneumoniae 
of equine origin does contain a typical 7.5 kb plasmid, although it is absent in the 
human isolates (Storey et al, 1993). Chlamydia plasmids are "cryptic", meaning 
that they convey no discernible phenotypes. On the other hand, Moulder et al 
(1984a,b), have reported on a 4 X 106 dalton extra-chromosomal DNA which is 
common to both C. trachomatis and C. psittaci thus, still confirming the lack of 
plasmids in C. pneumoniae strains. The mouse pneumonitis (MoPn) biovar is 
known to carry a plasmid (Palmer and Falkow, 1986) which apparently does not 
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cross hybridize with the plasmid from human strains. Restriction endonuclease 
analysis has shown that plasmids from different trachoma biovars are very similar 
and closely related to those of the LGV biovar. However, the C. psittaci plasmid 
has been found to be different from those of C. trachomatis (Stephens, 1990). 
Several studies including the one reported by Palmer and Falkow (1986), have 
found that, there are ten times (lOX) more copies of plasmid per Chlamydia 
chromosome equivalent. According to Comanducci et al, (1988, 1990), this 
plasmid could be required for growth within mammalian cells and might therefore 
play a role in C. trachomatis pathogenicity. 
Genes encoding heat shock proteins (HSPs) have been characterized. These include 
among others, genes encoding the genus-specific 57 kDa antigen, and the Dna-K 
homologue which has been cloned from all three species (Danilitton et al, 1990; 
Kornak et al, 1991). Gene cloning and sequence analysis of the gene encoding the 
57-kDa protein revealed that this protein was a member of the family of widely
conserved 60-kDa HSPs (hsp60), and also to be closely related to the groEL protein 
of Escherichia coli (Morrison et al, 1989a). This sarkosyl soluble hsp60 (groEL) 
has been associated with a delayed-type hypersensitivity response in chronic 
infections (Morrison et al, 1989b). Antibodies against the 75-kDa HSP (Dna-K) 
have been reported to neutralize infectivity even though the antigen does not elicit 
any delayed hypersensitivity activity (Maclean et al, 1988; Taylor et al, 1990). 
The groEL homologue of C. pneumoniae shows a 95 and 97% amino acid sequence 
similarity to C. trachomatis and C. psittaci homologs, respectively. Its Dna-K 
homologue on the other hand, shares only 87 % amino acid similarity with the C. 
trachomatis protein. 
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2.4.2 Antigenic Composition 
The main constituents of the chlamydia! outer membrane complex (COMP) are 
three cysteine rich proteins (CrPs) of M, 40, 60 and 12 kilodaltons (kDa) together 
with lipopolisaccharide (LPS). The 40-kDa component is the major outer 
membrane protein (MOMP) comprising 60% of the membrane protein and has a 
highly immunogenic species specific epitope (Caldwell et al, 198 l). This protein 
(MOMP), has been a major focus of attempts to develop a chlamydia! vaccine and 
more is known about its genetic structure and immunochemistry than of any other 
chlamydia! antigen. The MOMP encoding gene, termed ompl or ompA for all the 
C. trachomatis serovars have been completely determined (Dean et al, 1991; Hayes
et al, 1990; Lampe et al, 1993; Stephens et al, 1986; Stephens et al, 1987; Yuan 
et al, 1989). MOMP sequences are also currently available for five strains of C. 
psittaci and for two strains of C. pneumoniae (Carter et al, 1991). Campbell et al 
(1990), described a 39.5 kDa MOMP protein in all Chlamydiae, but others have 
found this protein to be cross reactive among chlamydia! species (Campbell et al, 
1990; Freidank, 1993; lijima et al, 1994). 
MOMP is believed to provide structural integrity to the chlamydia( cell wall by 
extensive disulphide bond cross-linking (Newhall and Jones, 1983; Carter et al, 
1991). This protein also has porin functions i.e has pore forming capabilities that 
permit exchange of nutrients for the reticulate body form (Bavoil et al, 1984). 
Monoclonal antibodies (MAbs) have been described which define neutralizing 
epitopes, suggesting that proteins encoded by ompl may serve as an adhesin (Su 
and Caldwell, 1991). Analysis of several MOMP genes have shown that the 
MOMP gene encodes for nine different amino acid sequences called regions. These 
consist of five highly conserved regions that do not vary from serovar to serovar, 
and four variable domains (VD! through VDIV) that contain serovar specific 
epitopes (Stephens et al, 1987; Lampe et al, 1993). The four VDs are presumably 
arrayed on the monomer face. Gene sequence studies indicate that this diversity 
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1s due to clustered nucleotide substitutions for closely related serovars and 
insertions and deletions for distantly related serovars (Stephens et al, 1987). 
The other major components of the COMP are the 60 kDa and 12 kDa CrPs with 
determinants that are biovar and species specific (Zhang et al, 1987). The 60 kDa 
protein appears as a doublet in the LGV biovar, whereas only a single band on 
polyacrylamide gel has been detected in the trachoma biovar (Batteiger et al, 1985). 
Unlike MOMP, which is present in RB, these two proteins are reported to be 
developmentally regulated and to play a role in the condensation process which 
accompanies the transition from RB to EB (Sardinia et al, 1988). Evidence by 
Newhall (1987), suggests the involvement of MOMP MOMP, MOMP 60 kDa and 
12-12 kDa links in conferring structural rigidity of the EB. These CrPs viz.
MOMP, 60 kDa and 12 kDa, are also similar in M, and structure in all Chlamydia 
species (Perez et al, 1993). A 98-kDa CrP has also been described; however, it 
could be detected only in the outer membrane complex of C. pneumoniae. This 
finding led to the idea that its presence might have a role in providing more rigidity 
to the membrane structure in order to sustain the pear shaped morphology that is 
unique to C. pneumoniae strains. 
All chlamydiae possess LPS, another major constituent of the COMP. ft is a heat
stable, lipoprotein carbohydrate complex with an immunodominant 2 keto 3
deoxyoctanoic acid as the reactive moeity. It contains genus specific epitopes 
(absent in other Gram negative bacterium) used for both sero diagnosis and 
antibody based chlamydia detection tests viz. Complement fixation and 
immunofluorescence. Although LPS antigens are surface exposed, they are 
incapable of stimulating the production of neutralizing antibodies as do MOMP 
antigens. Chemical cross linking studies show that MOMP lies within 10 
Angstroms (A) of LPS molecules (Birkelund et al, 1988). Monoclonal antibodies 
and monospecific polyvalent antisera to this LPS, have been used in enzyme 
Table I Differentiation and characteristics of the species and biovars of the genus Chlamydia 
(Modified from Bergey's manual of systematic bacteriology, Vol.I 1984) 
Characteristics C. trachomatis
Trachoma LGV
MOMP 40 000 MW + + 
Folate biosynthesis + + 
Net synthesis of ATP - -
Mot% G+C of DNA 44.0 41.9 
DNA, molecular weight (106) NIA 660 
% DNA homology to Trachoma biovar 100 100 
% DNA homology to TWAR 10 10 
Presence of 4 X 1()6 dalton + + 
plasmid 
Genus specific antigen + + 
(demonstrated by CF) 
Type speci fie antigens A Kc Ll L3 
(demonstrated by Micro IF) 
Number of serovars 14 4 
Natural Infections (host) Humans Humans 





Inclusion morphology Oval, vacuolar Oval, vacuolar 
Elementary body morphology Round Round 
Glycogen in inclusions + + 
Mouse lethality intracerebrally - + 
Follicular conjunctivitis in + -
lower primates 
Cell Culture Enhancement By: 
Centrifugation of inoculum onto + -
monolayer 
Effect of treatment of host cells + weak 
with DEAE dextran 
Plaques in mouse fibroblasts (L cells) - + 
NIA data not available 
Some strains do not contain plasmids:'Campbell et al, 1987; bStorey et al, 1993. 




















































immunoassay (EIA) systems for the detection of chlamydia! antigen 111 clinical 
specimens (Pugh et al, 1985; Howard et al, 1986). 
Since the introduction of the micro immunofluorescence (MIF) technique for the 
detection of antibody and for immunotyping by Wang and Grayston in 1970 (Wang 
and Grayston, 1970), 18 known serovars of C. trachomatis have been identified 
including three recently found serovars, Da, Ia, and L2a (Wang and Grayston, 
1991). These were defined by using polyvalent antisera (Wang and Grayston, 
1971) and monoclonal antibodies (Wang et al, 1985). C. trachomatis can be divided 
further into subspecies (serogroups) and serovars (serotypes). Serovars are each 
designated by a letter (A to K; and Ll to L3), and are distinguished by both the 
antigenic variation in the MOMP and the clinical disease they cause. Serovars are 
also grouped into three separate biovars: Trachoma Biovar, which include types A, 
B, Ba, and C frequently isolated from patients with ocular disease in areas of 
endemic trachoma (Fig. 2). Types D, E, F, G, H, I, J, and K, are primarily 
isolated from genital infections or neonatal infections acquired from the mother's 
cervix during birth, but they also cause ocular infections in adults. Most non LGV 
genital infections ( ~70%) are caused by serovars D, E, F, and G (Kuo et al, 
1983). Types Ll, L2, and L3 are isolated almost exclusively from LGY patients 
(Schachter and Meyer, 1969). The remaining biovar contains a single serovar, viz. 
the MoPn, which is involved in murine infections. 
The 18 serotypes, are further grouped into three subspecies (serogroups). Each 
serogroup corresponds to one of the three C. trachomatis complexes as defined by 
Yuan et al (1989) from the homologies of the MOMP amino-acid sequences (Table 
II). Within each group, the serovars can be arranged in a hierarchy of antigenic 
complexity (Wang and Grayston, 1971). MOMP M.-s also differ among serovars, 
with MOMPs of B Complex serovars having lower M . s than those of the C
Complex (Newhall et al, 1982). The first type, 8-Complex includes the L 1, L2, 
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L2a, E, D, Da, B, and Ba serovars. The second type, the F Complex includes 
serovars F and G; while the last type, the C-Complex, includes serovars A, C, J, 
K, H, I, Ia, and L3. 






L2, L2a, LI, E, D, Da, B, Ba 
F and G 
A, C, J, K, H, I, la, L3 

2.5 DISEASE SYNDROMES ASSOCIATED WITH CHLAMYDIA 
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Chlamydia! infections are a host of clinical syndromes caused by infection with any of the 
various chlamydia! serotypes. These infections are difficult to diagnose, with most being 
asymptomatic. Untreated asymptomatic infection may lead to serious sequelae, but if 
detected early, these sequelae can be eliminated by treatment with adequate doses of 
anticblamydial drugs. Chlamydia! infections are prevalent among adolescents and young 
adults regardless of their demographic background. The association of the organisms with 
different diseases are listed in Table III. 
Table III Clinical spectrum of Chlamydia 
SPECIES SEROTYPE DISEASE 
C. psittaci Many unidentified Psictacosis, ornithosis, 
serocypes Abortion, Endocarditis, 
C. pneumoniae Not known Community-acquired 
(TWAR) pneumonia, bronchitis, 
pharyngitis, sinusitis, 
?coronary artery disease 
C. trachomatis A, B, Ba, C Hyperendemic tracboma 
C. trachomatis LI, L2, L2a, L3 Lymphogranuloma venereum 
(LGV) 
C. trachomatis D,E,F,G,H,l,la,J,K 
Male Nongonococcal urethritis, 
Postgonococcal urethritis, 
Conjunctivitis, Proctitis, Reiter's 
syndrome, epididymitis, Sexually 
acquired arthritis (SARA) 
Female Mucopurulent cervicitis, Proctitis, 
Urethritis, Conjunctivitis, 
Salpingitis, Perihepatitis, Ectopic 
pregnancy, Endometritis, 
Infertility 
Neonates Inclusion conjunctivitis, 
Pneumonia, Otitis media, Rhinitis, 
Proctitis, Pharyngitis, Premature 
birth, ? Stillbirth 
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2.5.1 Chlamydia psittaci Infections
The distribution of C. psittaci infections is worldwide and virtually any species of 
bird can serve as host for the organism. Over 120 different species have been 
found to harbour the organism. C. psittaci is a common avian pathogen that causes 
sporadic cases of human ornithosis and psittacosis, feline pneumonitis and bovine 
abortion (Schachter and Dawson, 1979; Cassell et al, 1982; Yung and Grayston, 
1988). Human psittacosis is a zoonosis, meaning that, it is a disease in nature 
communicable to man. 
The organism is shed in the faeces of the birds, contaminating the environment and 
getting spread by aerosol. In humans, the lung is usually the organ involved most 
prominently. The organism enters the body via the respiratory tract and is 
transported to the reticuloendothelial cells of the liver and spleen which, due to 
infection, becomes enlarged thus, causing focal necrosis. C. psittaci infections 
(85 %) have been associated with exposure to infected avian species (Schachter and 
Dawson, 1979; Yung and Grayston, 1988; Yerweij et al, 1995). Person-to-person 
transmission has also been suggested; Bourke et al reported on a case involving one 
family member who had been exposed to pet birds and transmission of the 
organism to other unexposed family members (Bourke et al, 1989). 
Diagnosis is dependent on complement fixation (4-fold antibody rise) tests and chest 
x-ray results. The clinical course of psittacotic infection can vary widely, with the
incubation period ranging from 5-15 days or even longer (Schachter and Dawson, 
1979; Cassell et al, 1991; Cunha, 1991). Infection is abrupt in onset, starting with 
chills and fever (38-40.5°C) over a 2-4 day period. Other symptoms include a 
severe headache, malaise, anorexia, painful myalgia (particularly of the back and 
neck), arthralgia, and Horder's spots (a pale macular rash). A persistent non­
productive cough is prominent with complications such as consolidation and 
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crepitations in the lung, and evidence of hepatitis (Yung and Grayston, 1988; 
Bourke et al, 1989; Cunha, 1991). Severe pneumonia, respiratory and multi-organ 
failure may occur in severe cases. Overall mortality is estimated to be about 0. 7 % 
and a poor prognosis has often been associated with the elderly and those with 
leukopenia, renal impairment and multilobular involvement (Cassel I et al, 1982; 
Yerweij et al, 1995). C. psittaci has also been described as a pathogen in 
infectious endocarditis, as well as myocarditis and pericarditis; a possible 
involvement in myocardial infarction has also been suggested (Odeh and Oliven, 
1992). 
C. psittaci has also been implicated in human abortions. In the United Kingdom
(UK) and France, pregnant women (mostly farmers' wives) have been reported to 
have aborted after exposure to Chlamydia infected sheep during the lambing season 
(Roberts et al, 1982; Johnson et al, 1985). These women also exhibited antibody 
responses and chlamydiae were isolated from their placental samples. This 
aetiological association was confirmed by DNA restriction analysis, which showed 
that the strains isolated from human foetuses and placentae, were of ovine origin 
(Herring et al, 1987). 
2.5.2 Chlamydia pneumoniae Infections
Being a newly described species, C. pneumoniae has received considerable attention 
in the past decade. Much of the knowledge on this organism has been derived from 
serologic studies using the C. pneumoniae-specific micro-immunofluorescence 
(MJF) test. C. pneumoniae seems to be a primary human pathogen, and attempts 
to identify zoonotic reservoirs have been unsuccessful. It appears to have a 
worldwide distribution, with the antibody prevalence being higher in tropical 
countries than colder climates (Forsey et al, 1986; Wang and Grayston, 1990). 
The mode of transmission remains uncertain, though it is believed to be from 
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person to person via respiratory secretions; reports on the acquisition of infection 
by droplet aerosol during a laboratory accident supports the above suggestion 
(Kleemola et al, 1988; Mordhorst et al, 1992; Theunissen et al, 1993). The 
incubation period is several weeks, which is longer than that for other respiratory 
pathogens (Kishimoto et al, 1994; Mordhorst et al, 1994). 
Infection is most common among school-age children and very rare in children less 
than 5 years of age (Saikku et al, 1988; Wang and Grayston, 1990; Haid! et al, 
1994; Jantos et al, 1995), though data varies with geographic location. 
Seroconversion occurs from age 5 through 14 years, being accelerated through 
adolescence, slowing down in the older age group (Wang and Grayston, 1990). 
Seroprevalence is almost equal in both sexes under 15 years of age; however, due 
to other factors (smoking is also implicated), antibody titers are more markedly 
elevated in adult males than in adult females (Marrie et al, 1987; Wang and 
Grayston, 1990; Mendal I et al, 1995). 
The spectrum of diseases associated with C. pneumoniae is expanding, with most 
infections being mild or asymptomatic. C. pneumoniae is reported to cause an 
average of 10% of community acquired pneumonia cases and 5 % of bronchitis and 
sinusitis cases (Marrie et al, 1987; Grayston et al, 1989c). Studies have shown that 
only 10% of these infections result in clinically apparent pneumonia (Saikku, 
1992a; Grayston, 1992). C. pneumoniae causes acute respiratory disease associated 
with a non-productive or mildly productive cough, pyrexia, headache, sinusitis and 
pharyngitis (Grayston et al, 1986; Marrie et al, 1987; Grayston et al, 1989b; 
Grayston, 1992; Grayston et al, 1993; Pruckl et al, I 995). Initial reports 
emphasized atypical pneumonia clinically resembling that associated with 
Mycoplasma pneumoniae (Grayston et al, 1986); however, pneumonia caused by 
C. pneumoniae cannot be clinically differentiated from other pneumonias.
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The role of C. pneumoniae as an opportunistic pathogen among 
immunocompromised persons has not been well defined. The organism has been 
successfully isolated from the lungs of human immunodeficiency virus (HIV) 
infected patients (Augenbraun et al, 1991) and is believed to be responsible for 
about 20 % of respiratory infections as identified by polymerase chain reaction­
enzyme immunoassay (PCR EIA) and serology (Gaydos et al, 1993). 
Seroepidemiologic studies have shown evidence of chronic infection due to C. 
pneumoniae in the elderly, smokers and in patients with chronic obstructive 
pulmonary disease. Complications associated with the disease include myocarditis 
associated with sudden death (Wessleri et al, 1992), Guillain Barre Syndrome in 
a child (Haidl et al, 1992) and with atherosclerosis (Thom et al, 1991; Saikku et 
al, 1992b; Kuo et al, 1993; Poulakkainen et al, 1993; Mendall et al, 1995). C. 
pneumoniae has been reported in cases with reactive arthritis and Reiter's 
Syndrome (Braun et al, 1994). 
Evidence of the presence of C. pneumoniae in atheromatous plaques has been 
obtained by electron microscopic studies, immunocytochemical staining and PCR 
testing of coronary atheroma (Kuo et al, 1993). Then Campbell et al, proceeded 
to demonstrate that 33 % of patients with primary lesions and 86 % of patients with 
re-stenosis had chlamydia! DNA associated with plaque formation (Campbell et al, 
1995). However, Weiss et al, were unsuccessful; they failed to detect the organism 
in atheromas by culture, electron microscopy or PCR (Weiss et al, 1994). Even 
though these studies show the association of C. pneumoniae with atheromatous 
plaques, the role of C. pneumoniae infection in the pathogenesis of atherosclerosis 
is still unknown. 
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2.5.3 Chlamydia trachomatis Infections
Chlamydia trachomatis is amongst the most prevalent bacterial pathogens. Its 
preferred site of infection is primarily, epithelial surfaces in the eye and genital 
tract. It is also a major cause of reproductive tract morbidity throughout the world, 
particularly in women. C. trachomatis also causes ocular infections, the most 
common being trachoma. Trachoma is the commonest infectious cause of blindness 
affecting about 500 million people, of whom 7 million become blind (Dawson et 
al, 1981). 
Chlamydia! infections are difficult to diagnose and require very expensive screening 
programmes to detect and eradicate. Urinary tract infections caused by C. 
trachomatis are much more commonly symptomatic in men than in women. Both 
gonorrheal urethritis and C. trachomatis urethritis may cause "sterile" pyuria, and 
both infections may be asymptomatic. Infections in males include among others 
non gonococcal urethritis, post-gonococcal urethritis and epididymitis (Storey et al, 
1987). 
Chlamydia! genital infections in women are important because of their frequency 
and their consequences. They are mostly asymptomatic and may go undetected for 
a long time. The recovery of C. trachomatis from the cervix of sexually active 
women ranges from 5 35 % , depending on the characteristics of the population. 
Risk factors for genital chlamydia! infections include young age (..$.24 years), single 
marital status, concomitant STDs, multiple sexual partners, history of new 
partner ,and use of nonbarrier or oral contraceptives. (Handsfield et al, 1986; 
Wolner-Hanssen et al, 1990). C. trachomatis causes a spectrum of genital 
infections in women; clinical manifestations of chlamydia! lower genital tract 
include postcoital bleeding or induced mucosa! bleeding, mucopurulent cervical 
discharge, acute urethral syndrome, acute Bartholinitis, and proctitis. 
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Transmission of chlamydia! infections from mother to baby occurs when a baby 
passes through the birth canal of a mother with cervical chlamydia! infection. 
These babies are at a higher risk of being infected or colonized with the organism, 
than babies born through caesarian section. Clinical manifestations include 
inclusion conjunctivitis seen in 30-40 % of babies, and pneumonia, occurring in 10
20% of these babies. Apart from the eyes and respiratory tract, infection at various 
other sites have been documented viz. the middle ear, nasopharynx, pharynx, 
rectum and vagina. These infections remain asymptomatic until 6-7 months post­
partum due to the suppressive effect of maternal antibody (Hobson et al, 1983). 
2.5.3.1 Trachoma 
Trachoma is the commonest cause of ocular morbidity and preventable blindness 
in the world (Darougar and Jones, 1983). It is endemic in tropical and subtropical 
countries, with North Africa, Middle East and northern parts of the Indian 
subcontinent, affected the most. Studies conducted in Tunisia (Hanna et al, 1976), 
Ethiopia (De Sole, 1987; De Sole and Martel, 1988), Gambia (Bailey et al, 1989), 
and in Kenya (Loewenthal and Pe'er, 1990), show that trachoma is still a major 
cause of blindness in most parts of Africa, with the prevalence reaching 45.1 %. 
It is also prevalent in the northern regions of Transvaal (now called Northern 
Province) in South Africa (Ballard et al, 1983; Bucher and Ijsselmuiden, 1988; 
Scott, 1993), but there are no reports of this disease in Kwazulu Natal (KZN) 
province. Trachoma is caused by serovars A, B, Ba and C of C. trachomatis, and 
can be spread from eye to eye, affecting both children and adults. It may begin 
as a mucopurulent conjunctivitis and is often complicated by secondary bacterial 
infection. The incubation period could vary from 2 14 days but, it is difficult to 
es tab I ish the date of contact. Trachoma is defined as a chronic keratoconjunctivitis 
characterized by follicles, palpebral conjunctiva! scarring and pannus keratitis with 
scarring of the cornea; other symptoms include mucopurulent discharge, swelling 
of eyelids, redness, irritation and itching. The blinding consequences of trachoma 
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are caused by conjunctiva( scarring that in turn leads to trichiasis (inturned 
eyelashes), then corneal scarring. The degree of scarring increases with the 
duration and severity of the conjunctiva! inflammatory disease (Dawson et al, 1989; 
Dawson et al, 1990). 
2.5.3.2 Inclusion Conjunctivitis 
Inclusion conjunctivitis infections affect both adults and newborn babies. These 
infections are caused by C. trachomatis oculogenital serovars (D through K), and 
are acquired by direct contact between eyes of normal individuals and material 
(including genital secretions) from infected individuals. The incubation period of 
adult conjunctivitis is generally 1-2 weeks. The disease is manifested acutely with 
foreign body sensation, photophobia, rnucopurulent discharge, and follicular 
conjunctivitis often with keratitis. The follicles, unlike those of Trachoma, are 
more pronounced in the lower than the upper lid. Pannus (a membrane like 
structure produced by superficial vascularization of the cornea with infiltration of 
granulation tissue) is unusual but well documented (Viswallingam et al, 1983). In 
the absence of reinfection, the lesions tend to heal over a period of several months 
to 2 years. 
Chlamydia( eye infection in neonates, is more common than gonococcal ophthalmia 
in the United States. Neonatal inclusion conjunctivitis is usually subclinical with 
the symptoms appearing within l week post partum. The disease is characterized 
by an acute copious mucopurulent discharge, inflammation or oedema of the 
eyelids, and conjunctiva( erythema. If left untreated, the disease tends to resolve 
over 2-3 months but, may later result in conjunctiva! scarring. Complications are 
seen mostly in untreated infants. 
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2.5.3.3 NeonataJ Pneumonia 
The possible involvement of C. trachomatis in causing afebrile pneumonitis was 
first suggested by Schachter et al. in 1975, then Beem and Saxon (1977) proceeded 
to characterize the syndrome even further (Schachter et al, 1975; Beem and Saxon, 
1977). The onset is gradual, ranging from 2-14 weeks after de! ivery. Antecedent 
or concomitant conjunctivitis is frequently noted. Initial manifestation is rhinitis, 
followed by a staccato cough and tachypnea. Other symptoms include malaise, 
cyanosis, and poor weight gain. Evidence that C. trachomatis is a cause of 
pneumonia in the newborn include among others, the recovery of the organism 
from neonatal lung specimens. Chest x-rays reveal hyperexpansion with 
symmetrical diffuse interstitial and patchy alveolar infiltrates. Laboratory findings 
include eosinophilia and elevated serum immunoglobulin levels. Serous otitis media 
is reported as a complication of pneumonia but may also occur independently. The 
diagnosis is confirmed by culture, antigen detection of a pharyngeal aspirate, or the 
appearance of IgM antibodies to C. trachomatis. Left untreated, the disease runs 
a benign course, leading to apparent recovery. 
2.5.3.4 Genital Infections in the Male 
2.5.3.4.1 Non-gonococcal Urethritis 
Non-gonococcal urethritis (NGU) is the most common STD in men in industrialised 
countries, with up to 50-60% of the cases caused by C. trachomatis (Holmes et al, 
1975; Felman and Nikitas, 1981). In South Africa, N. gonorrhoeae is still the 
leading cause of urethritis in adult males with a prevalence of 70-80 % . In our own 
study on adult male urethritis in Durban, C. trachomatis was responsible for 28 % 
of the NGU cases (Small and Maleka, 1994). There is no clinical difference 
between chlamydia! and non-chlamydia! NGU. The incubation period is between 
1 and 3 weeks; by which time patients complain of dysuria and urethral irritation, 
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and on investigation, a mucoid or mucopurulent urethral discharge is often found. 
Chlamydia) infections may be symptomless even though mild erythema or any signs 
of urethritis may be present. A presumptive diagnosis of NGU is defined as > 4 
polymorphonuclear cells per field in a Gram-stained smear using magnification 
XIOOO, and > 15 polymorphonuclear cells per field in the resuspended sediment 
of a centrifuged 10 ml first catch urine specimen examined at magnification X400 
(Swartz and Kraus, 1979; Shafer et al, 1986). Cell culture and antigen testing can 
also be used as diagnostic measures. Chlamydia urethritis tend to be less 
symptomatic compared to gonococcal urethritis. Organisms also implicated in 
causing between 10 25 % of NGU cases include among others, Ureaplasma 
urealyticum, Candida albicans, Trichomonas vaginalis, Mycoplasma genitalium and 
Herpes simplex virus (Bowie and Holmes, 1977; Bowie et al, 1977; Oriel, 1981; 
McCormack and Taylor Robinson, 1984; Shanson, 1988). 
2.5.3.4.2 Post-gonococcal Urethritis 
Post-gonococcal urethritis (PGU) is defined as a persistent NGU following 
treatment for gonococcal urethritis in men. It is due to co infection with Neisseria 
gonorrhoeae and one of the organisms known to cause NGU. PGU results after 
treatment with a single dose of penicillin, cephalosporin or a quinolone which is 
directed against eradication of gonorrhoea and not of chlamydia. Co infection with 
N. gonorrhoeae and C. trachomatis is seen more frequently in heterosexual men
(15 30%) than homosexual men (5 %). Approximately 80% of men infected by N.
gonorrhoeae and C. trachomatis develop PGU after single dose therapy (Oriel et 
al, 1975; Oriel, 1983). C. trachomatis is responsible for 30 50% of PGU cases. 
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2.5.3.4.3 Epididymitis 
The aetiology of acute epididymitis varies with age and sexual activity of the 
patient. In young men under the age of 35 years, infection is often due to C. 
trachomatis and N. gonorrhoea, with the former being responsible for 30 60 % of 
the cases. Where gonorrhoeae is uncommon, C. trachomatis is usually the major 
cause (Berger et al, 1978; Doble et al, 1989a; Eley et al, 1992). In South Africa, 
Fehler et al, (1989) reported a 17 % prevalence of C. trachomatis in sexually 
acquired acute epididymitis, and I 8 % of the patients who were negative by culture, 
had elevated antichlamydial antibody titres of _?_l :64. In men over 35 years of 
age, epididymitis is often associated with instrumentation, and caused by 
Enterobacteriaceae and Pseudomonas aeruginosa. Symptoms of epididymitis 
include unilateral scrotal pain, scrotal swelling, tenderness and fever. When 
urethral discharge is associated with epididymitis in older men, gonococcal or 
chlamydia! infection is likely to be the cause. Whereas the presence of midstream 
pyuria and bacteriuria in older men without urethral discharge, is suggestive of 
Enterobacteriaceae and other bacterial infection. 
2.5.3.4.4 Prostatitis 
This condition occurs in both acute and chronic forms. Symptoms of prostatitis 
include perinea! or suprapubic discomfort, dysuria, frequency, fever and urethral 
discharge. N. gonorrhoeae and Enterobacteriaceae have been found to cause acute 
prostatitis (Oriel and Ridgway, 1983). However, the role of C. trachomatis in this 
disease is dubious. Although C. trachomatis has not been recovered from prostatic 
fluid of men with chlamydia! urethritis and has reportedly been isolated from 
prostatic tissue (Poletti et al, 1985; Doble et al, 1989b), there is still no convincing 
evidence to associate C. trachomatis with either acute or chronic prostatitis. 
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2.5.3.4.5 Proctitis and Proctocolitis 
Among homosexual men engaging in anoreceptive intercourse, non-LGV serovars 
of C. trachomatis have been associated with proctitis which is characterized by 
inflammation limited to the rectum, while LGV serovars seemed to be associated 
with either proctitis or proctocolitis (Quinn et al, 1981; Quinn et al, 1983; Munday 
and Taylor-Robinson, 1983). With non LGV serovars, symptoms include mild-to­
moderate rectal discharge, mild anorectal pain, tenesmus, and constipation. Rectal 
mucosa is usually erythematous and friable; a rectal Gram stain reveals numerous 
polymorphonuclear leukocytes and biopsy specimens show a polymorphonuclear 
leukocyte infiltrate in the lamina propria. r n contrast, symptoms due to LGY 
serovars are severe as that seen in Crohn's disease; the rectal mucosa usually shows 
haemorrhages and ulcers, fever and inguinal lymphadenopathy may occur as well 
(Quinn et al, 1981; Quinn et al, 1993). 
2.5.3.4.6 Reiter's Syndrome 
Reiter's syndrome is an asymmetric, reactive polyarthritis or tenosynovitis 
associated with uveitis and urethritis (Stamm and Holmes, 1984; Sands, 1992); 
however, Reiter related disease manifestations are also, frequently seen. In the 
absence of uveitis, Rheumatoid-factor negative arthritis associated with genital 
infection, is referred to as sexually acquired reactive arthritis (SARA) (Keat, 1983). 
Approximately 1-3 % of NGU cases are complicated by this condition. The 
syndrome has been found to occur 20 times more frequently in men than in women 
and like all Rheumatoid-factor negative arthritis, also significantly more often in 
HLA B27 antigen-positive individuals (Inman et al, 1987; Keat et al, 1987). There 
is usually multiple joint involvement in descending order of frequency knees, 
ankles, wrist and metatarsophalangeal joints. Mucocutaneous manifestations 
include balanitis, vulvitis, and conjunctivitis. Other ocular manifestations include 
keratitis, iritis, and retinitis. In patients with Reiter's syndrome, synovial fluid 
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culture for C. trachomatis is negative, although fluorescent antibody testing of 
synovial fluid has demonstrated the presence of C. trachomatis elementary bodies 
in the synovial fluid (Keat et al, 1987). 
2.5.3.5 Genital Infections in Females 
2.5.3.5.1 Mucopurulent Cervicitis 
Chlamydia! infection of the cervix is the most common genital infection in women 
in the industrialised world and almost 50% of these infections are asymptomatic. 
C. trachomatis is the major cause of mucopurulent cervicitis (MPC) and pelvic
inflammatory disease (PIO). C. trachomatis accounts for 60% of the cases and co
infection with N. gonorrhoeae is common (Brunham et al, 1984). As with post
gonococcal urethritis in men, women with gonorrhoea and concurrent C. 
trachomatis infection receiving antimicrobials only active against N. gonorrhoeae, 
often have persistent post gonococcal chlamydia! cervicitis. 
MPC is the counterpart in women of urethritis in men. It often goes unrecognized 
because of the absence of abundant discharge, itching or foul smell. Observation 
of > 10 polymorphonuclear leucocytes per high power field on a Gram's stain is 
diagnostic of mucopurulent cervicitis. Apart from the mucopurulent discharge, 
presumptive diagnosis of MPC include a positive swab test (by culture or antigen 
detection), increased erythema, oedema, and induced mucosa] bleeding in the area 
of ectopy and the transformation zone (Paavonen et al, 1986; Sands, 1992). 
Histopathological findings include the presence of dense stromal inflammation 
(plasma cell infiltrations), intraepithelial and intraluminal inflammation, and well­
formed lymphoid follicles comprising transformed lymphocytes (germinal centres) 
(K iviat et al, 1990). 
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2.5.3.5.2 Pelvic Inflammatory Disease 
Pelvic inflammatory disease (PID) refers to infection of the uterus, fallopian tubes, 
and adjacent structures. PID is almost always an ascending infection in which 
pathogenic micro organisms spread from the vagina and cervix to the upper genital 
tract (McCormack, 1994), causing severe pelvic organ damage. The true incidence 
and prevalence of PID is unknown, although C. trachomatis is estimated to be 
responsible for 20 30% of PID cases. In our study at King Edward VIII hospital, 
Durban, C. trachomatis was detected in 24 % of the patients presenting with PJD 
(Chetty and Maleka, 1995). The clinical spectrum of chlamydia! PID ranges from 
subclinical endometritis to frank salpingitis, pelvic peritonitis, infertility, and 
ectopic pregnancy (Mardh et al, 1989). PID in sexually active women is usually 
caused by N. gonorrhoeae and C. trachomatis alone, in conjunction with 
endogenous flora of the lower abdominal tract. According to Sweet et al (1986), 
clinical symptoms vary with respect to C. trachomatis serovar group. They found 
that women with group F G infections tend to have milder symptoms when 
compared with infections caused by Band C group infections (Sweet et al, 1986). 
Any PIO and subclinical PID in particular, is very difficult to diagnose and the 
traditional clinical and laboratory criteria for the diagnosis of PIO are considered 
to be insensitive and non-specific. Thus, laparoscopy (gold standard), endometrial 
biopsy, or vaginal ultrasound examination have been incorporated in the diagnosis 
of PID in order to improve accuracy (Paavonen et al, 1987; Eddowes et al, 1990; 
Sellers et al, 1991). 
Clinically, the symptoms and signs of chlamydia! endometritis or salpingitis are 
usually mild (Stanley et al, 1990). Histological evidence of endometritis is seen 
in approximately 50% of women with mucopurulent cervicitis. Endometritis 
usually arises after instrumentation of the uterus and has been reported to occur in 
up to 20% of asymptomatic chlamydia infected women undergoing suction abortion 
(Blanco et al, 1985). Symptoms typical of endometrial chlamydia! infection include 
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heavy, prolonged or irregular menses. Women without symptoms of abdominal 
pain, who have chlamydia! cervicitis often have a plasma cell endometritis with or 
without lymphoid follicles (Paavonen et al, 1985; Kiviat et al, 1990). Salpingitis 
on the other hand, usually presents with lower abdominal pain occasionally 
described as atypical or mild and often coinciding with the onset of menses, as in 
gonococcal PID (Svensson et al, 1980). Common physical findings include a 
mucopurulent cervical exudate, uterine and adnexal tenderness, and pain on 
movement of the cervix. At laparoscopy, women with chlamydia! salpingitis have 
been found to have disease as severe as women with gonococcal salpingitis. 
Laparoscopic findings often reveal severe tubal inflammatory changes out of 
proportion to clinical findings. 
PIO is the single most preventable cause of infertility and adverse pregnancy 
outcome. The majority of patients with tubal factor infertility or tubal pregnancy 
have serum antibodies to C. trachomatis indicating past chlamydia! infection 
(Mardh et al, 1989; Paavonen, 1990). Women with salpingitis are at considerable 
risk of developing infertility due to peritubal adhesions or tubal occlusion. Each 
repeat episode of PID doubles the risk of tubal damage (Brunham et al, 1985; 
Patton et al, 1990). The prevalence of antibody to C. trachomatis is higher among 
women with infertility and tubal occlusion than in comparison groups. Subclinical 
and asymptomatic episodes of PJD has also been associated with increased risk for 
ectopic pregnancy, which contributes to 50% of infertility cases (Cates and 
Wasserheit, 1991). A 2 to 3-fold increased risk for ectopic pregnancy in women 
with an IgG titre 2:_l :64 has been reported in a case control study. Ruptured 
tuboovarian abscesses have been noted in advanced PIO patients as well as 
periappendicitis with serosal inflammation of the appendix (Paavonen, 1990). 
Tissue damage due to delayed type hypersensitivity is caused by chlamydia! stress 
proteins belonging to 60 and 70 kDa heat shock protein families characteristic of 
several micro organisms known to cause chronic infections (Morrison et al, 1989b; 
Danilitton et al, 1990). 
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Data on the importance of C. trachomatis as a cause of spontaneous abortions, 
stillbirths, chorioamnionitis, premature rupture of membranes, premature delivery, 
and neonatal deaths are conflicting. Martin et al (1982), were the first to report 
an increased risk for stillbirth and neonatal death, which were occurring 10 times 
more frequently in women infected with chlamydia. They found the gestation 
period to be significantly shorter in women with antenatal chlamydia) infections 
(Martin et al, I 982). C. trachomatis IgM sero-positivity has been I inked with poor 
obstetrical outcome. This was confirmed by the findings of Gravett et al (1986) 
and Sweet et al (1987) in the case of pre-term labour and premature rupture of 
membranes. 
2.5.3.5.3 Acute Perihepatitis (Fitz-Hugh Curtis Syndrome) 
Acute perihepatitis was described for the first time in 1919 (cited: Bolton and 
Darougar, 1983), however, its association with C. trachomatis as the aetiological 
agent, has only recently been described (Sands, 1992). ft is estimated that between 
3-5 % of women with acute PTO develop perihepatitis with symptoms of pleuritic
right upper quadrant abdominal pain, and tenderness often without pelvic pain. 
However, adnexal tenderness consistent with salpingitis has been recorded as well. 
The characteristic "violin-string" adhesions seen between the liver and the anterior 
abdominal wall which are associated with C. trachomatis infection, were first 
thought to be caused by N. gonorrhoeae; however, 80 % of patients with proven 
Fitz-Hugh-Curtis Syndrome were found to be positive for C. trachomatis by culture 
or serology, while only 10% were positive for N. gonorrhoeae (Holmes et al, 
1990). 
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2.5.3.6 Lymphogranuloma Venereum 
Lymphogranuloma venereum (LGV) is a systemic disease caused by one of the 
three serovars (Ll, L2, and L3) within the species C. trachomatis (Schachter and 
Osoba, 1983; Perine and Osoba, 1984; Osoba, 1987). This venereal disease occurs 
mainly in tropical and subtropical areas of southeast Asia, India, east and west 
Africa, the Caribbean, and certain parts of the United States and South 
America. The few sporadic cases reported in Europe are mainly imported. Cases 
of LGV in these areas, have been largely reported in adults, however, there have 
been no studies of antenatal and paediatric cases in these endemic areas over the 
past three decades despite the introduction of more specific tests for LGV. LGV 
is usually described in three stages with the primary stage involving a superficial 
lesion, usually on the external genitalia, which develops 1 to 2 weeks after 
exposure (Van Dyck and Piot, 1992). The lesions are painless and may be 
vesicular or ulcerative. 
The secondary stage, occurring a week or more after the primary stage, 1s 
characterized by inguinal lymphadenopathy. This is the typical stage with which 
men often present at clinics. Symptoms include a tender cord like swelling along 
the shaft of the penis that is caused by lymphangitis, buboes (enlarged inguinal 
lymph nodes) that are classically multilocular, and fever and chills. Women do not 
often present with this form of the disease. Suppuration may occur in the lymph 
nodes, resulting in a multilocular abscess (Latif, 1990; Martin, 1990). 
If there is a delay in treatment, the disease usually progresses to the tertiary stage, 
known as the anogenital syndrome. Due to the asymptomatic nature of chlamydia! 
infections and the lack of obvious early manifestations of LGV, women often seek 
medical help when the disease is at its tertiary stage. This stage is characterized 
by the inflammation and scarring of the genitalia and anorectal canal; fistulae, 
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strictures, and genital elephantiasis may also occur. In females, this form of 
elephantiasis of the vulva is known as an "esthiomene". Often, genital elephantiasis 
caused by chronic fibrosis, and destruction of inguinal lymph nodes and rectal 
strictures, caused by the destruction and fibrosis of perirectal and pelvic lymph 
nodes, may require surgical treatment (Schachter and Osoba, 1983; Perine and 
Osoba, 1984; Piot and Laga, 1989; Van Dyck and Piot, 1992; Chopda et al, 1994). 
f nfection has been noted to occur on vanous sites other than the genitalia, 
depending on where the organism was implanted. Parinaud's oculoglandular 
syndrome may develop if the eye is the site of infection, and when implantation is 
within the oral cavity, cervical lymphadenopathy occurs. LGV proctocol itis is also 
common among homosexual men. Other systemic complications include hepatitis, 
pneumonia, arthritis, and meningoencephalitis. 
2.6 LA BORA TORY METHODS FOR THE DIAGNOSIS OF CHLAMYDIAL 
INFECTIONS 
The choice of diagnostic methods for the detection of chlamydia! infections depends on 
factors such as the number of samples to be processed, cost of the test, the sites of 
infection, and the purpose of the test. For laboratory diagnosis, isolation in cell culture 
systems has traditionally been the most accurate method. For this reason, it has been 
considered as the "gold standard" against which other methods were measured (Lefebre 
et al, 1988; Ridgway and Taylor-Robinson, 1991; Taylor-Robinson and Thomas, 1991). 
In the last few years, a number of non-culture methods have been introduced and the use 
of non-invasive techniques has increased. However, the success of the laboratory culture 
of chlamydia or any other test to be performed, is directly related to the collection of the 
appropriate (good quality) specimen by the physician and then adequate preservation of 
chlamydiae in the specimens before and after arrival in the laboratory. Effective swabbing 
of the urethra in men (by inserting the swab 2cm or more into the urethra, then rotating 
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it) and the cervix in women (by removing excess ectocervical mucopus prior to collection), 
has been the traditional approach for specimen collection (Centers for Disease Control and 
Prevention CDC, 1993). Chlamydiae are obligate intracellular parasites that infect 
columnar epithelium, therefore, the specimen must contain columnar epithelial cells. 
As chlamydiae are extremely labile organisms, even with the use of a special transport 
medium and maintenance of the specimen at 4°C, the viability of any chlamydiae present 
is quickly lost if the specimen is kept for more than 24 hours. Jf rapid transport to the 
laboratory is not possible, storage at 70°C is preferred when cell culture is to be 
attempted. The nature of the swabs may also influence the recovery of chlamydiae, 
particularly in cell culture systems. Dacron swabs on metal or plastic shafts should be 
used because of the toxic effect wood and cotton have on the growth of this fastidious 
organism (CDC, 1993). Other disadvantages of cell culture technique are that it is 
expensive, labour-intensive and takes several days to produce a result (Young, 1990; 
Taylor Robinson, 1992). These limitations have led to the development of non-culture 
techniques, thereby limiting the use of cell culture to specialised and research laboratories. 
Non culture diagnostic techniques include: direct visualisation of the orga111sms us111g 
fluorescein labelled monoclonal antibodies (direct immunofluorescence DfF),detecting 
the presence of antigens in specimen by enzyme immunoassay (EIA), and nucleic acid 
hybridization (DNA probe) test. The main advantages of these methods is that viability 
of organisms is not important and the specimen can be kept for several days after 
collection, at either room or refrigerator temperature. Recent developments include the 
polymerase chain reaction (PCR), which is highly sensitive and allows the detection of 
even the smallest amounts of specific nucleic acids using repeated amplification steps of 
a specific target sequence. 
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2.6.1 Tissue Culture Isolation 
Although the sensitivity of various tissue culture systems is accepted to be less than 
100 % , they remain the standard for identifying Chlamydiae. Since the initial 
isolation and growth of Chlamydia in embryonated hen's eggs in 1955, a number 
of cell lines have been developed for culture. McCoy (mouse fibroblasts), HeLa 
229 (Helen Lang's carcinoma of cervix), HL (human lung), BHK 21 (baby hamster 
kidney) and BGMK (Buffalo Green Monkey Kidney) are among the cell lines that 
have been used (Kuo et al, 1972; Ripa and Mardh, 1977; Hobson et al, 1982; Cles 
and Stamm, 1990). These cell lines have proved to be at least IO-fold more 
sensitive than the yolk sac method. Cles and Stamm (1990) reported to have found 
HL cells to be more sensitive than other cell I ines in the isolation of C. 
pneumoniae. However, McCoy cells which are mouse fibroblasts (L cells), are 
widely used as the cell line of choice for the isolation of C. trachomatis. 
A number of monolayer cell replication inhibitors have been used in the 
pretreatment of different cell lines to increase the sensitivity of C. trachomatis 
isolation. Such inhibitors favour the organism in its competition for ATP with the 
host cells. These include: irradiation, cyclohexamide, IUdR (5 iodo-2
deoxyuridine), cytochalasin B, and mitomycin C (Kuo et al, 1972; Ripa and 
Mardh, 1977; Sompolinsky and Richmond, 1974; Evans and Taylor-Robinson, 
1979; Woodland et al, 1987). Centrifugation at forces between 2000 3500 g 
enhance infection of monolayers by the organisms. This is thought to result from 
an improved contact of the microbes with cells. Iodine, Giemsa, methylene blue, 
acridine orange, DNA binding dyes, and immunofluorescence among others, have 
been utilized to identify inclusion bodies. Many workers prefer using specific 
fluorescent monoclonal antibodies which are very sensitive thus offering more rapid 
detection of chlamydia! inclusions (Thomas et al, 1977). 
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2.6.2 Enzyme hnmunoassays 
Enzyme immunoassays (EIAs), were introduced in the late 1980s, although only 
those with IDEIA were available. Unlike cell culture, EIAs are easy to perform, 
lacks subjectivity, and allow large numbers of samples to be tested within a few 
hours at a low cost. The drawback about these tests is the grey zone that exists 
between definite positive readings of optical density (OD) and definite negative 
readings. All currently available EIA tests utilise either polyclonal or monoclonal 
antibodies directed predominantly against chlamydia! LPS (Ridgway and Taylor­
Robinson, 1991), thus making them all genus specific. The widely used EIAs are 
MicroTrak (Syva), Chlamydiazyme (Abbott Diagnostics), IDEIA (Novo Nordisk), 
Clearview Chlamydia (Unipath), and Kodak Surecell (Kodak) (Caul and 
Paul, 1985; Pugh et al, 1985; Barnes, 1989; Arumainayagan et al, 1990; 
Hammerschlag et al, 1990; Young et al, 1991; Kellogg et al, 1992; Shafer et al, 
1993). 
These tests detect Chlamydia antigen using an antibody labelled with an enzyme 
and colour substrate. The results are then measured spectrophotometrically. In 
view of the fact that the antibody reacts to any type of Chlamydiae, a blocking 
agent is added to decrease the false-positive rate. Unfortunately, the sensitivity of 
these assays has varied from study to study, and in general are less than that of cell 
culture and false positive reactions are not uncommon. The use of EIAs in testing 
rectal specimens is highly discouraged due to the number of false positives that 
occur (Rothburn et al, 1986). Different studies have reported sensitivities and 
specificities ranging from 70-96% and 97-99% respectively (Thomas et al, 1989). 
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2.6.3 Direct Fluorescent Antibody (DFA) Test 
Whereas culture requires the existence of viable organisms, immunofluorescence 
techniques do not. These non-culture diagnostic methods using monoclonal 
antibodies directly on patient material have been found to be rapid, simple and 
sensitive and comparing well with culture (Tam et al, 1984). There are several 
commercially available kits; some use species-specific monoclonal antibodies that 
bind to MOMP, while others use genus-specific antibodies that bind to LPS 
(Alexander et al, 1985; Cles et al, 1988; Stamm and Mardh, 1990). The former 
detect only C. trachomatis, while the latter detect all three species and are unable 
to distinguish between them. 
The widely used commercial direct immunofluorescence (DIF) test is the Syva 
MicroTrak (Syva) which takes about 30 min to perform. This test, which uses 
monoclonal antibodies directed against MOMP, the specimen is smeared onto a 
glass slide treated with a fluorescent monoclonal antibody that binds to the 
elementary body (EB) of C. trachomatis. The technique is also useful for the 
evaluation of specimen adequacy, as the presence or absence of columnar epithelial 
cells can easily be noted. The major disadvantage of DIF is the necessity for a 
skilled microscopist because of difficulty in differentiating between true 
elementary bodies (EBs) and artifacts or background immunofluorescence. Several 
studies have recommended that a minimum of 10 EBs should be visualised to 
consider a specimen positive. This criteria has resulted in improved specificity 
(87-99% for men; 82-100% for women) but decrease in sensitivity (70-100% for 
men; 68-100% for women) (Taylor-Robinson and Thomas, 1991). Despite that, 
DIF test has been reported to be more sensitive and specific when compared with 
EIAs. 
2.6.4 DNA Probes and Polymerase Chain Reaction 
45 
When DNA probes were first introduced, radioisotopic (1251) DNA probes 
complementary to the ribosomal RNA (rRNA) of the target organism, were 
available commercially. However, they did not prove to be user-friendly and have 
now been replaced by a non-isotopic label. Paiva et al (I 984), were the first group 
to publish information about DNA probes for detecting C. trachomatis. The DNA 
probe test, checks for chlamydia! rRNA by linking luminescent DNA with rRNA. 
This test, although specific, is not sensitive (Gratton et al, 1990; Ossewaarde et al, 
1992). 
Due to the apparent lack of sensitivity of many nucleic acid probes, the polymerase 
chain reaction (PCR) was developed for the diagnosis of chlamydia! infection. This 
technique was developed in 1987 by Kary Mullis in an effort to imitate the 
replication of genetic material which occurs in nature when cells divide PCR is an 
in vitro method based on the amplification of a specific nucleic acid fragment of 
defined length and sequence. Amplification of greater than 106 fold can be 
obtained from very small amounts of template. In practical terms, this is achieved 
by means of two flanking oligonucleotides sequences called primers and 
repeated cycles of amplification with the enzyme DNA polymerase and 
deoxynucleotide triphosphates (dNTPs - dATP, dCTP, dGTP and dTTP) (Saiki, 
1990). The use of a thermostable enzyme isolated from the bacterium Thermus 
aquaticus, called Taq DNA polymerase, has made it possible to automate this 
procedure. 
PCR has significantly transformed the usefulness of nucleic acid probe tests and is 
now being used in many laboratories worldwide. It has so far, been applied in a 
number of areas such as prenatal diagnostics, forensic medicine, detection of 
foreign organisms and many others. The first report on the use of PCR for the 
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detection of C. trachomatis in clinical specimens came m 1989 (Griffais and 
Thibon, 1989). Since then, several studies have been conducted using plasmid, 
MOMP or rRNA gene targets (Claas et al, 1990; Frost et al, 1991). PCR has 
proved to be extremely sensitive and specific (Mahony et al, 1992; Jaschek et al, 
1993; Frost et al, 1993) but prone to false positive results if laboratory 
contamination is not meticulously avoided. Other disadvantages are that, it relies 
highly upon the knowledge of the sequence in order to design the primers, and also 
that only a small part of a gene can be conveniently amplified and examined at any 
one time. In addition to that, there are many complex interactions which occur 
during the PCR, therefore, making it unlikely that there will be a set of conditions 
optimal for al I reactions. 
Commercial DNA amplification system for C. trachomatis such as Amplicor 
(Roche Products Ltd.), have been available since late 80's. The recent system, 
Ligase Chain Reaction (LCR) is similar to PCR and can detect C. trachomatis from 
both swab and first void urine specimens. The LCx (Abbott Diagnostics) C. 
trachomatis assay uses the nucleic acid amplification method LCR to directly detect 
the presence of C. trachomatis cryptic plasmid DNA in clinical specimens. This 
plasmid is found in the conserved regions of all serovars of C. trachomatis at 
approximately 10 copies per elementary body (EB) or reticulate body (RB) (Palmer 
and Falkow, 1986), but is not found in other species (Joseph et al, 1986). The 
LCx assay employs four oligonucleotide probes designed in pairs, to recognize and 
hybridize to a specific target sequence located within the C. trachomatis DNA. 
The two pairs of oligonucleotide probes are labelled with immunoreactive chemical 
groups called haptens, and only the LCR amplified products with both haptens 
covalently attached, generate a fluorescence signal which is detected by the LCx 
analyzer. 
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Studies performed using this plasmid-based assay (LCR) have reported sensitivities 
ranging from 87% to 98% and specificities of 99.8% to 100% (Chernesky et al, 
1994a; Chernesky et al, 1994b; Schachter et al, 1994; Bassiri et al, 1995; Lee et 
al, 1995). LCR thus provides a rapid, highly sensitive and specific noninvasive 
screening method for detecting genital chlamydia! infections in both men and 
women. 
2.6.5 Serology 
Chlamydia! infections, usually those resulting in deep-seated infections, induce in 
individuals the formation of antibodies that can be detected serologically. Several 
serological techniques such as agglutination, immunodiffusion, haemagglutination, 
have been used in the diagnosis of chlamydia! infections by detecting antibodies to 
the three species of the genus (Taylor-Robinson and Thomas, 1991). In common 
with the use of serology for the diagnosis of many infections, a change in antibody 
titre is the most reliable criterion, particularly the demonstration of a fourfold or 
greater rise in titre (Hanuka et al, 1987). The oldest and most common method 
has been the complement fixation test which detects the genus specific anti-LPS to 
measure antibody. This test is insensitive in that it only detects the deep-seated 
chlamydia! infection, such as psittacosis (ornithosis), LGV, infant pneumoniae and 
PTD but not localized ocular or genital infections; it is also incapable of 
differentiating between causative organisms. This lack of sensitivity and specificity 
has led this test to be superseded by other tests such as the micro
immunofluorescence (Micro-IF) (Ridgway and Taylor-Robinson, 1991; Taylor­
Robinson, 1992). 
The Micro-IF was devised by Wang and Grayston in 1970 and is the only sensitive 
and specific serological assay for any of the Chlamydiae (Treharne et al, 1983; 
Barnes, 1989). This test with TWAR antigen, is specific for C. pneumoniae. By 
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using this technique, 15 chlamydia! serovars were defined during the first decade 
of chlamydia! serotyping. This test can also distinguish between antibodies in the 
IgG and IgM fractions, which makes it helpful in distinguishing recent from past 
infection, and reinfection from primary infection (Taylor Robinson and Thomas, 
1991). However, this test is technically demanding, and the antigens are not yet 
commercially or rather readily available. 
Characterization of C. trachomatis isolates has always been carried out by 
serotyping since the 1960s. It was initially done with a bioassay based on serovar
specific prevention of toxic death after intravenous chlamydia! challenge in mice, 
and later replaced with an indirect microimmunofluorescence (micro IF) method 
which employs polyvalent mouse antiserum. The test has been simplified somewhat 
by the use of formalinised C. trachomatis organisms (Wang et al, 1979) or the use 
of reticulate bodies as antigens (Yong et al, 1979), but the methodology is generally 
considered too complex for routine clinical laboratories. 

3.1 STUDY PERIOD 
PATIENTS AND METHODS 
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The clinical aspects of this study were carried out between 3 July and 22 August 1995. 
All clinical assessments and specimen collection were performed during this period. 
3.2 PATIENTS 
A total of 247 adult male patients attending the City Health STD Clinic, Durban, were 
investigated. Patients presenting with any form of genital ulcer(s) during the study period 
were recruited. The exclusion criteria for participation in the study were the use of 
antimicrobial agents in the preceding two weeks, the inability to provide a urine specimen, 
and refusal to be included in the study. Patients were informed of the purpose of the study 
and the need for specimen collection. Only patients giving verbal consent were included 
in the study. This study was approved by the Ethics Committee of the Faculty of 
Medicine, University of Natal. 
3.3 CLINICAL EVALUATION 
All patients were evaluated by means of a standardized interview form (Appendix 6) that 
included information on patients' age, marital status, past and current sexual history, and 
genital signs and symptoms. A detailed genital examination was performed by the study 
clinician. 
3.4 COLLECTION AND TRANSPORT OF SPECIMENS 
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Genital ulcer specimens were collected after cleaning the base and edges of the ulcer(s) 
with a cotton tipped swab and a subsequent swab was used to prepare smears on clean 
glass slides for Gram staining (Dangor et al, 1990). 
A plastic loop was then used to scrape cellular material off the edges of the ulcer(s) and 
immediately placed in 0.5 ml of phosphate buffered saline (PBS). 
Endourethral specimens were obtained by inserting narrow shafted calcium alginate tipped 
swabs 2 to 3 cm into the urethra. Swab specimens were used for the preparation of 
smears on clean slides for C. trachomatis antigen detection by the Direct 
Immunofluorescence (DIF) test (MicroTrak, Syva), for Gram staining, and direct 
inoculation onto Modified New York City medium (MNYC) and into 2 ml Chlamydia 
transport medium (CTM) for the isolation of N. gonorrhoeae and C. trachomatis 
respectively (Hoosen et al, 1993). 
All inoculated agar plates were immediately placed into candle extinction jars and 
transported to the laboratory within 2 hours, where the plates were streaked out and then 
incubated at 37°C, in 5% CO2 for 48 hours (h). 
Three tubes (5 ml each) of venous blood were collected aseptically from each patient, from 
a peripheral vein. These were kept at room temperature until transported to the 
laboratory. 
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Each patient was requested to collect about 20 ml of the first portion of voided urine 
sample in a sterile plastic, screw cap tube. The urine specimens were kept at 4°C until 
transported to the laboratory. 
3.5 PROCESSING OF SPECIMENS 
The PBS ulcer samples (0.5 ml) were vortexed and 100 µ.l aliquots were added into 
different culture transport media i.e chlamydia transport media (CTM), viral transport 
media (VTM), granuloma inguinale transport media (GIM) and Tryptic Soy broth 
(containing 1 % Isovitalex), for the isolation of C. trachomatis, herpes simplex virus, 
Calymmatobacterium granulomatis and Haemophilus ducreyi respectively (Ripa and Mardh, 
1977; Dylewski et al, 1986; Hoosen et al, 1987; Taylor Robinson and Thomas, 1991; 
Kharsany et al, 1997). All culture specimens were transported to the laboratory and 
processed within 24 h. 
With regard to Chlamydia culture, of the 247 clinical specimens collected, the first 200 
specimens (P 1 45, and U 1 155) were processed within 24 h of collection, while the last 
47 specimens (U 156 202) were stored at 70°C for a week prior to processing. The 
reason for the delay in processing of the last 47 specimens was due to excessive workload 
which had accumulated from the first 200 specimens. 
Smears for DIF were air dried, fixed with acetone, wrapped in foil and then stored at 
20°C until processed (Taylor Robinson and Thomas, 1991).
Serum was separated from clotted blood specimens and aliquoted into three cryovials. One 
vial was sent to the Serology laboratory, Department of Medical Microbiology, King 
Edward VIII Hospital (KEH), Durban, for syphilis serological tests i.e screening with the 
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Rapid Plasma Reagen (RPR) test (Romanowski, 1991; Sischy, 1991). All positive sera 
were titred and confirmed by the Treponema pallidum haem agglutination (TPHA) test and 
the Fluorescent Treponema Antibody Absorption (FTA Abs) test (Hunter, 1990; Sischy, 
1991). The second vial was sent to the Serology laboratory, Department of Virology, 
KEH, for human immunodefiency virus (HIV) serology which comprised screening with 
an ELISA (Abbott Diagnostics) and confirmation by indirect immunofluorescence. 
Aliquots of 10 ml of unspun urine specimens were pipetted into polyethylene cryotubes, 
labelled and then frozen at 70°C for the performance of the Ligase Chain reaction (LCR) 
testing (LCx, Abbott Diagnostics). 
3.6 PROCESSING OF SPECIMEN FOR CHLAMYDIA TRACHOMATIS 
3.6.1 Direct Antigen Detection of C. trachomatis
Endourethral smears were examined using a C. trachomatis direct fluorescent 
antibody reagent test (MicroTrak, Syva). The reagent contains fluorescein 
isothiocyanate conjugated (FITC), purified murine monoclonal antibodies specific 
for C. trachomatis, Evans Blue counterstain and suppressors of nonspecific staining 
in a protein stabilized buffer solution. The use of highly specific monoclonal 
antibodies allows the visualization of individual chlamydia! elementary bodies in 
direct patient specimens. Tests were performed according to the manufacturer's 
instructions. The procedure used was as follows: 
The direct specimen reagent together with the acetone fixed slides (removed from 
20°C) were left at room temperature for 30 minutes before use. Smeared slides
were stained using 30 µI of diluted monoclonal antibody which was spread over the 
entire area of the well. The slides were incubated at room temperature for 15 min 
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in a moist chamber. After incubation, slides were gently rinsed in distilled water 
for 10 seconds to remove unbound antibody and then air dried. A drop of 
mounting fluid was added to the centre of each well and a coverslip mounted. 
Slides were examined with a fluorescent microscope (Olympus) at a wavelength of 
540 nm. A positive diagnosis was made when two or more elementary bodies were 
observed. Elementary bodies (EBs) were identified as characteristic individual pin­
points of medium to bright apple green fluorescence. These were then visualised 
using lO0X oil objective for verification. To quality control the performance of 
the staining procedure and the microscope, both C. trachomatis positive and 
negative control slides provided by the manufacturer were stained and read in 
parallel with each series of test slides. 
3.6.2 Culture and Isolation of Chlamydia trachomatis 
3.6.2.1 Reconstitution of Cultured Cells 
An ampoule/vial (to be reconstituted) containing 106/ml McCoy cells was removed 
from the liquid nitrogen freezer and immediately plunged into a bottle containing 
sterile triple distilled water (tdH20) at a temperature of 37
°C. The thawing process 
has to be rapid because of the trauma of the process of freezing and thawing to the 
cells. Immediately upon t_hawing, the vial was wiped with 70% alcohol and opened 
aseptically in the laminar flow safety cabinet and the contents diluted 1: 10 in 
growth medium [Eagle's minimum essential medium (MEM) with L glutamine (2 
mM)] in a mini flask. Heat inactivated Foetal Calf Serum (10% FCS) (i.e 1 ml in 
10 ml of MEM), was added and the flask placed at 37°C in a 5% CO
2 incubator. 
After 24 h, the cells were trypsinized if they were confluent and if not, the medium 
was changed and the cultures re incubated at 37°C in 5 % CO2 until confluency. 
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3.6.2.2 Heat Inactivation of Serum 
A 500 ml bottle of foetal calf serum was removed from 20°C and placed at room 
temperature for 3 4 h before thawing completely in a 37°C waterbath. The bottle 
was removed from the waterbath, agitated to mix the contents and then, placed into 
a 56°C preheated waterbath with the water level above the serum level. Another 
bottle with an equivalent water volume with a thermometer inserted inside, was 
placed in the same waterbath as a control. The temperature of the waterbath was 
monitored to ensure that it stayed at 56°C while the serum was occasionally mixed 
by swirling. When the temperature in the control bottle had reached 56°C, a timer 
was set for 30 min. At 15 min intervals, the temperature was checked and the 
bottle swirled. After 30 min incubation, the bottle was removed from the waterbath 
and the serum aliquoted into 20-ml bottles and stored at 20°C until required. 
3.6.2.3 Trypsinization/Passaging Procedure 
When the cells had reached the required percentage of confluency, the spent 
medium was removed and the cell monolayers washed thrice with 5 ml of PBS. 
The washing fluid (PBS) was decanted and replaced by 2 ml of warmed 
trypsin/EDT A solution (equal parts of 0.25 % trypsin and 0.02 % EDTA). The 
flask was swirled gently in order to spread the solution evenly over the cell 
monolayer. The trypsin was allowed to work for 20 seconds, then decanted leaving 
a small amount (approximately 100 µ,I) to cover the surface of the flask. Table IV 
depicts the relationship between flask size and volume of trypsin/EDT A used. 
Table IV Flask size - Volume of trypsin/EDT A added 
a. 75 cm2 flask - 2.5 to 5.0 ml
b. 105 cm2 flask 5.0 to 10.0 ml
c. 850 cm2 roller bottle 10.0 to 20.0 ml
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It was found that, the longer the time frame between confluency and subculturing, 
trypsinization took longer. Thereafter, the flask was incubated at 37°C until cells 
detached as a film from the flask surface (ca. 2 min). Cells were immediately 
resuspended in 3 ml of PCS to stop the action of the trypsin and thereafter topped 
with 7 ml of MEM. The cell suspension was titurated thrice i.e pipetting back and 
forth, using a syringe and an 18G needle and once through a 25G needle in order 
to break cell clumps and obtain single, dispersed cells. 
The cell suspension was transferred to a new flask and topped with 20 ml of growth 
medium containing 10% PCS and antibiotics (Appendix 1.2). The flask was 
incubated at 37°C for 4 days before the next passage. After two days of 
incubation, the medium was changed with MEM containing 5 % PCS and 
antibiotics. On the fourth day, the flask was removed from the incubator and cells 
trypsinized in the same manner as above. After trypsinization, the McCoy cells 
were seeded at a 1 :40, 1 :20 and 1 :5 ratio and incubated; occasionally, the cells 
were counted by the Trypan Blue exclusion method (see below) using a 
haemocytometer and an inverted light microscope. 
3.6.2.4 Determination of Cell Numbers 
For an accurate determination of cell numbers in suspension cultures, a 
haemocytometer was used. This consists of two chambers, each of which is 
divided into nine large (1 mm) squares. The fom large squares at the corners are 
each ruled into sixteen smaller squares and the large square in the middle is ruled 
into twenty five smaller squares which in turn are ruled into sixteen even smaller 
squares. The depth of the chamber is 0.1 mm therefore, to convert to ml, one has 
to multiply by 104 (1/10000). 
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Prior to counting, the haemocytometer and the cover glass were properly cleansed 
with distilled water (H20), followed with absolute ethanol and then wiped dry. The 
cover glass was placed over the haemocytometer chamber. Cell suspension (0.5 
ml) was transferred into a 1.8 ml vial and mixed with 0.5 ml of diluted Trypan
Blue dye. Trypan Blue is used to differentiate between viable and dead cells, since 
it is excluded by the membrane of viable cells whereas the nuclei of dead cells take 
up the stain. Using a clean glass capillary tube (Becton Dickinson), both chambers 
of the haemocytometer were filled by capillary action. Cells in the 5 large squares 
(each corner square and the middle square) of both chambers including cells lying 
on the top and the left hand margins of each square were included in the count for 
that square. The cells similarly located on the bottom and the right hand margins 
were omitted and vice versa. When over 10% of the cells represented clumps, then 
the entire sequence was repeated. 
The total number of cells in the original culture was calculated as follows: 
cells/ml = average count per square X 104
Total cells = cells per ml times any dilution factor e.g 2, if 0.5 ml of cells plus 
Trypan blue (0.5 ml) is used X total volume of cell preparation from which sample 
was taken. 
E.g n = total no. of cells counted in 5 large squares 
y = 2 (dilution of solution in trypan blue) 
6-1 = 5 (volume of cell preparation dilution i.e 0.5 ml X 2) 
n/5 = no. of cells in one large square 
Equation: 104 ny = 104 X n X 2 X 5 
5 5 
Count was repeated to check reproducibility. The desired cell concentration was 
then adjusted by diluting the cells in growth medium with a factor of X/5 where 
X = the number of cells calculated in the squares. 
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Fig. 3 Diagram of a haemocytometer. The ruled area of the improved Neubauer 
counting chamber. 0 = count; X = do not count 
3.6.2.5 Cryopreservation of McCoy Cells 
After trypsinization and cell count, the cell mixture was resuspended in growth 
medium at a concentration of 2.5 to 4.0 X 106 cells/ml. McCoy cells were stored 
at 106 in 1 ml cryo vials. For example: if in the remaining 19.5 ml of MEM/cell 
mixture, there were approximately 15.210.000 cells, the number of cells was 
divided by 106 to get the number of cells per vial to be expected. In this case, the 
amount was 15.21, therefore, 15 vials were used. The cell suspensions during the 
procedure were kept cool at all times in an ice box. 
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The 19. 5 ml of the tissue culture fluid in the tissue culture flask was then poured 
into 15 ml centrifuge tubes and the tubes centrifuged at 2100 rpm for seven min. 
After centrifugation, the supernatant was discarded leaving the cell pellet at the 
bottom. This was topped up with 15 ml or more of freezing medium (MEM) 
containing 10 % FCS and 10 % glycerol. 
The suspension was titurated using a syringe and an 18G needle and thereafter, 
1 ml aliquots of the suspension were transferred into sterile cryotubes labelled with
the type of cell line, passage number and the date. The vials were placed at 4°C 
for 1 h in a polystyrene box, after which, the vials were stored at 70°C overnight 
giving a cooling rate of 1°c per min. The following day, the vials were removed 
from the 70°C freezer and stored in liquid nitrogen container. At approximately 
3 monthly intervals, one vial was taken out and reconstituted to check whether the 
cells were still viable. 
3.6.2.6 Seeding of McCoy Cells 
Having trypsinized the cells, counting and adjusting the cell concentration in growth 
medium, 1 2 ml of McCoy cell suspensions were planted onto 13 mm glass 
coverslips contained in 15 mm-diameter (I-dram) disposable flat bottomed track 
vials. Approximately 1 X 105 to 2 X 105 cell concentration was always selected to 
give a light, confluent monolayer after 24 to 48 h of incubation at 37°C in a CO2 
incubator. If the monolayers were to be used the next day, a dilution of 2 X 105 
cells/ml was used. 
It is possible to dispense cells at a lower concentration, incubating for a longer time 
until they are confluent. In this case the required cell count must be adjusted 
accordingly. 
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Prior to returning the track vials to the incubator, they were gently swirled to 
remove any bubbles beneath the glass coverslips. For optimal results, the cells 
were used within 24 to 72 h after reaching confluency. 
3.6.2. 7 First Passage Isolation 
Prior to inoculation of McCoy cell lines, the following were carried out: 
Each track vial was examined using an inverted microscope (objective X5, ocular 
X8) to check whether the cells had formed a confluent monolayer. Only those with 
70 80% cell confluency were selected; those with cracked tubes, broken coverslips,
"patchy" distribution of cells or overcrowded cells were discarded. Each track vial 
cap was then marked with the corresponding specimen number. 
For the clinical specimens: sterile glass beads were added aseptically in each 
specimen tube. The specimens were vortexed with glass beads for 2 min. 
This procedure is safer and more convenient than sonication, although the latter has 
been reported to increase sensitivity. 
The isolation technique for C. trachomatis using McCoy cells was performed as 
described by Ripa et al (1977), with slight modification. To inoculate the 
monolayers, growth medium was aspirated from each track vial and monolayer 
rinsed once with PBS. This was replaced with 0.5 ml of cycloheximide overlay 
medium (Bio Whittaker) and 1 ml of the inoculum (1 :2) [two vials per specimen]. 
Cycloheximide is a glutarimide antibiotic which inhibits the DNA and protein 
synthesis of eukaryotic cells, but does not affect prokaryotic cells such as 
Chlamydia. 
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The specimen was then centrifuged onto the cell monolayer at 3000 rpm at 35°C 
for 1 h. The infected monolayers were incubated at 35°C in the atmosphere of 5 % 
CO2 for 2 h before the medium was aspirated and replaced with 1 ml of 
cycloheximide overlay medium (Bio-Whittaker). 
The cells were re incubated for a further 48 to 72 h at 35°C in 5 % CO2, after 
which one of the cultures (one of the two vials for each specimen) was fixed in 
95 % ethanol and stained with 30 µl of FITC monoclonal antibody, Chlamydia 
trachomatis confirmation test (MicroTrak, Syva) and examined for inclusion 
forming units using a fluorescence microscope (Olympus). 
This test was performed according to the manufacturer's instructions. A known 
positive control and a negative control (uninoculated McCoy cell monolayer) were 
processed and stained in parallel with every batch of patient specimens. 
3.6.2.8 Fixing, Staining and Evaluation of McCoy Cells 
After 48 h incubation of the cultures, one vial from each set of specimen vials was 
selected and placed on a tray. The medium was aspirated carefully from the vials 
without disturbing the cell monolayers on the coverslips. The monolayers were 
immediately rinsed twice with 1 ml of PBS by slowly adding PBS on the side of 
the track vial, then gently agitating the vial for at least 1 min and finally aspirating 
PBS with a pasteur pipette. 
To fix the cultures, 1 ml of 95 % ethanol was added to the vials and left to stand 
for 10 min. The ethanol was aspirated from the vials and the coverslips removed 
using forceps. A drop of DPX mountant was placed onto clean, labelled 
microscope slides upon which, the coverslips were placed with cell side facing 
upwards. These were left to dry overnight, at room temperature in the dark. 
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Slides were stained the next day or wrapped in foil and stored at 20°C until 
required. Slides used immediately or if stored at 20°C were brought to room 
temperature, and the detection of Chlamydia trachomatis was confirmed using 
tluorescein isothiocyanate (FITC) conjugated monoclonal antibody. FITC 
conjugated monoclonal antibody (30 µ1) was added to each monolayer, covering the 
entire coverslip. The slides were incubated at 37°C for 30 min in a moist chamber. 
The antibodies were not allowed to dry onto cells since drying may cause non
specific binding. 
Following incubation, excess reagent was aspirated and the slides rinsed in 
deionized water for 10 sec. Slides were left to air dry. A drop of mounting 
medium was placed onto each appropriately labelled microscope slide and a square 
coverslip placed on top of the drop. 
Slides were examined for the presence of characteristic apple green round 
inclusion forming units (IFU) using a fluorescence microscope (Olympus). 
Inclusions were confirmed at lOOX magnification. For a positive result, 2 or more 
inclusions were required. Slides were read within 24 h of staining or stored at 4°C 
in the dark to be read within 48 h or at -20°C until read. 
3.6.2.9 Second Passage Isolation 
When a blind passage of negative material was required, then, 72 to 96 h post­
inoculation i.e after first passage, the one remaining vial of each specimen was 
62 
passaged. Sterile glass beads were added to each of the vials, the cell monolayer 
disrupted and the cells detached by shaking with glass beads on a vortex mixer for 
20 to 30 sec. 
Cycloheximide overlay base medium (0.5 ml) (Bio Whittaker) was added to two 
fresh vials (at least 70% confluent) and the monolayers were inoculated as 
described above (section 3.6.2.7). 
After 48 h incubation one vial of each specimen was fixed, stained and read as 
described above (section 3.6.2.8). When no inclusions were found on reading the 
first and second passage coverslips, then the specimen was considered negative for 
C. trachomatis.
3.6.2.10 Storage of Chlamydia Cultures 
C. trachomatis positive and negative cultures in the remammg vials, were
processed as in second passage (3.6.2.9). If more than two vials were processed 
from each specimen, then suspensions from the same inoculum were combined. 
An equal volume of 0.4 sucrose phosphate buffer (0.4 S P) was added to each 
suspension. Then 0.1 ml of FCS for each millilitre (ml) of the mixture was added. 
1 ml of the culture mixture was dispensed into 1. 8 ml cryo vials and labelled with 
the specimen number, the number of times that it had been passaged and the date. 
The same data was also recorded in the laboratory culture book. The isolates were 
then stored at 70°C. 
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3.6.2.11 Repassage of Chlamydial Isolates 
Stored isolates ( 70°C), which were known to be infected with chlamydia, were 
used as the inoculum for the newly prepared monolayers. Following the same 
isolation method as detailed above, more than two track vials for each isolate were 
inoculated depending on the number of chlamydia! inclusions that were expected 
to be present in the infected monolayer. After centrifugation, change of medium 
and incubation, one vial was fixed and stained, one stored and the other(s) 
repassaged into more track vials as appropriate. This procedure was continued 
until an adequate number of isolates was stored. 
3.6.3 Ligase Chain Reaction (LCR) 
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The plasmid based LCR assay for the detection of C. trachomatis was performed 
according to the manufacturer's instructions (LCx, Abbott Laboratories). Three 
different areas were used in order to prevent amplicon contamination. These 
consisted of Area 1 (sample preparation area i.e the hood) where specimen 
processing and addition to LCR reaction mixture took place, Area 2 
thermocycling and pulse centrifugation area, and Area 3 where loading of reaction 
cells and the amplification vials into the carousel and detection of amplified product 
took place. 
3.6.3.1 Specimen Processing 
On the day of LCR testing, the 247 urine specimens were completely thawed and 
briefly vortexed to resuspend any settled material. 
Using a pipettor with aerosol barrier pipette tips (Art, S.A. Scientific), 1 ml of 
urine was dispensed (in the hood) into appropriately labelled 1. 7 ml Urine 
Specimen Microfuge Tube from the Urine Specimen Preparation Kit (No. 3B21). 
The samples were centrifuged at 13,000 X g for 10 min (Eppendorf Centrifuge, 
Abbott). After removal of the supernatant, the pellet was resuspended in 1 ml 
Urine Resuspension Buffer which is provided with the LCx kit and the tubes were 
sealed with cap locks and vortexed until the pellet was resuspended. The samples 
were then placed in an LCx dry bath at 97°C for 15 min to lyse the cells. After 
being cooled to room temperature ( ~ 15 min), the urine samples were held at 4°C 
until further processing. 
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As the pellet was often translucent, fine tipped pipettes were used to remove the 
supernatant so as not to disturb or dislodge the pellet. The time period between 
centrifugation and removal of supernatant was also kept to less than 15 min. 
3.6.3.2 DNA Amplification 
For testing, 100 µI of the Activation Reagent was added to each bottle of negative 
controls and calibrators. After vortexing, 100 µl of each processed urine sample 
and of each control was pipetted into appropriately labelled, individual unit dose 
tubes containing 100 µI of the LCR reaction mixture. 
Controls consisted of two negative controls and two calibrators of purified DNA 
with each batch of samples processed. The mixture contained four oligonucleotide 
probes specific for C. trachomatis cryptic plasmid, NAD, magnesium, thermostable 
DNA polymerase and a thermostable DNA ligase which acts to fill in and join 
adjacent oligonucleotide primers that line up on complementary target DNA, 





CTGAAACGITGAGAACCACCATCTGAACCAGT A IT ACCTGAAAACAAC < -Target ( + strand) 
HAPTEN 5' 3' 5' 3'HAPTEN 
Probe 1 -> A-GACTTTGCAACTCTTGGTGGT AGA pGGTCAT AATGGACTTTGTTG- < -Probe 3 
HAPTEN HAPTEN 
Probe 2-> A-CTGAAACGTTGAGAACCACCAp GAACCAGT ATT ACCTGAAACAAC-B <-Probe 4 
3' 5' 3' 5' 
5' 3' 
GACTTTGCAACTCTTGGTGGT AGACTTGGTCA TAATGGACTTTTGTTG< -Target (- strand) 
Fig. 4 DNA sequences for plasmid target and probe set 6917 6964 used in the 
LCx C. trachomatis assay. 
66 
Samples were then transferred to Area 2 where they were placed immediately into 
the LCx thermal cycler (Model 80056). Only 48 samples at one time were 
amplified for 40 cycles over a 2 hour period. The amplification protocol was as 
follows: 




93°C for 1 sec 
59°C for 1 sec 
62°C for 1 min 10 sec 
Cycle count 40 cycles 
The Assay Step Cycle file is "linked to" the Soak File at 25°C, indefinitely. 
Two negative controls as well as two calibrators were assayed with each batch of 
samples. After thermocycling, the controls, calibrators and the samples were pulse­
centrifuged for 10 15 seconds and then transferred to Area 3 where LCx reaction 
cells were placed into a Micro particle Enzyme Immuno Assay (MEIA) carousel. 
3.6.3.3 LCx Detection and Inactivation of Amplification Product 
The LCx Chlamydia amplification vials were placed into the LCx reaction cells in 
the following order: negative controls in positions 1 and 2, calibrators in positions 
3 and 4 and specimens in the remaining positions. The LCx Chlamydia Detection 
Reagent Pack was removed from 4°C storage, gently inverted 5 times making sure 
that no bubbles were formed, then the reagent pack bottles were opened in 
increasing numerical order: 1 4. Thereafter, the run was initiated. 
Amplification products were qualitatively detected in an LCx analyzer (Abbott 

3.6.4 Processing of Specimens For Polymerase Chain Reaction (PCR) 
3.6.4.1 C. trachomatis Culture Preparation for PCR 
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Reference strains and clinical strains of C. trachomatis were recovered on 
cycloheximide-treated McCoy cell monolayers (in duplicate) by incubating for 72 
h at 35°C in 5 % CO2• Inclusions were detected using the direct fluorescent culture 
confirmation test (MicroTrak, Syva). Serial passages were carried out until the 
monolayers had 15 to 30 inclusions per high-power microscopic field and 30-50% 
of the cell monolayers were infected. Sterile glass beads were added to each track 
vial and the cells disrupted by vortexing for 1 min. 
3.6.4.2 Chromosomal DNA Extraction 
Cell cultures were pelleted (1200 rpm, 20 min), chromosomal DNA extracted 
(Peterson et al, 1989; Sambrook et al, 1989), quantified using a spectrophotometer 
(Gene Quant II - Pharmacia, Biotech) and electrophoresed on O. 8 % agarose gel (70 
V/cm, 1-2 h). Chromosomal DNA extracted from McCoy cells infected with 
different genital ulcer specimens was intact, as seen by the presence of 1-kbp band 
(Plate 1). 
3.6.4.3 Amplification for the Detection of Chlamydia trachomatis 
Specific amplification of the cryptic plasmid and MOMP genes of Chlamydia 
trachomatis was undertaken using a set of divergent primers (synthesized by 13-
cyanoethyl phosphoramide Model 8600, Milligen Biosearch) to amplify a conserved 
region of these genes. For the specific amplification of the cryptic plasmid gene 
yielding a 452 bp product, a sense 5' plasmid 24-mer that is homologous to 
nucleotides 2318-2341 (oDnaBL) and a 3' antisense primer homologous to 
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Table V Location and sequences of the sense and antisense primers used to amplify 







5' CAA CAG CGT AGA GTT GGT TTC CTA 3' 





"The primer pair was chosen in the highly conserved region of C. trachomatis cryptic plasmid (Comanducci 
et al, 1990). 
boDnaBL and oDnaBR primers amplify all known C. trachomatis serovars. 
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Table VI Locations and sequences of the sense and antisense primers used to amplify 







5' AGC CTT ATG ATC GAC GGA ATT 3' 
5' AAT ACC GCA AGA TTT TCT AGA 3' 




•o5'MOMP primer is found in the conserved region of all C. rrachomatis strains at the amino-terminal end
of the MOMP gene.
boDVDIV acts as a PCR amplification primer for all serotypes and variants of C. rrachomatis.
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3.6.4.4 PCR Reaction Mixture 
PCR reaction mixture (final volume 100 µl) comprised of 10 mM Tris
hydrochloride (HCl), pH 8.0; 50 mM potassium chloride (KCI); 1. 75 mM 
magnesium chloride (MgC12); 0.01 % gelatin; 200 µM each deoxynucleoside 
triphosphate (dNTPs); 1.0 µM of each primer; and 2.5 units Thermus aquaticus 
(Taq) polymerase (Amplitaq, Cetus); and 10 µl of DNA sample. The PCR reaction 
mixture was overlaid with 100 µI of mineral oil (Sigma), subjected to 40 cycles of 
amplification in a thermal cycler 480 (Perkin Elmer, Cetus) (1 min at 94°C, 1 min 
at 67°C, 1 min at 72°C), following an initial denaruration at 94°C for 4 min and 
were completed by an extension of 7 min at 72°C. The same reaction mixture and 
conditions as described above, were repeated for the primer set for the specific 
amplification of the MOMP gene except that the annealing temperature was 55°C 
(Lampe et al, 1993). PCR negative controls were provided by reactions containing 
all of the components without addition of the template. The products were analysed 
by electrophoresis on 0.8% ethidium bromide stained agarose gels, and 
photographed on a 302 nm ultraviolet transilluminator. 
3.6.4.5 PCR Sensitivity for the Cryptic Plasmid and MOMP Genes 
Ten fold serial dilutions 00-2 to 10- 10) of a known positive control (C. trachomatis
L2 DNA) were tested for end point PCR sensitivity for the cryptic plasmid and 
MOMP genes, using their respective primers. 
3.6.5 IMMUNOTYPING OF CHLAMYDIA TRACHOMATIS ISOLATES 
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The protocol for immunotyping of chlamydia isolates is the modified version of Barnes et
al ( 1985) and Suchland and Stamm ( 1991). This indirect microimmunotluorescence 
(micro IF) serotyping assay employs a panel of monoclonal antibodies (MAb) which 
encompasses all 18 currently recognized serovars of C. trachomatis. The MAbs used in 
this study were provided by Dr M. Lampe (Division of Allergy and Infectious Diseases, 
Department of Medicine, University of Washington, Seattle, USA). Viable organisms are 
a requirement for this technique. 
3.6.5.1 Isolation of C. trachomatis 
The culture positive isolates were removed from 70°C, quickly thawed (50°C), and 
then inoculated (100 µI) onto cycloheximide-treated McCoy cell monolayers in 
96 well microtitre plates. The isolation procedure, incubation steps and the
conditions, were the same as described previously in 3.6.2. 7 and 3.6.2.8. After 
48 to 72 h incubation, chlamydia! inclusions were detected by a direct fluorescein 
isothiocyanate conjugated (FITC) monoclonal antibody (MAb) to Chlamydia 
lipopolysaccharide (CF 2). Isolates with a lower initial inclusion count i.e < 50% 
monolayer infection per well, were inoculated and serially passaged (two to five 
times) in track vials until 50 to 100% (i.e 2.. 20 inclusion forming units, IFU) of 
the monolayers were infected. Infection of the monolayers was observed by 
viewing the vials with an inverted microscope. Vials containing > 50% infected 
monolayers as indicated by the presence of cytoplasmic refractile cellular inclusions 
characteristic of C. trachomatis, were used for chlamydia! antigen preparation. 
These isolates, were stored at 70°C until they were processed for typing. 
3.6.5.2 Culture Preparation for Titration of Chlamydial Isolates 
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A flask containing confluent McCoy cell monolayer was trypsinized as described 
previously (3.6.2.3), and the cell numbers determined by the trypan blue exclusion 
method using a haemocytometer as previously described (3.6.2.4). The cells were 
diluted accordingly (depending on the number of microtitre plates needed) to get 
a final concentration of 3.5 X 105 cells per well of a 96 well microtitre plate. This 
cell concentration gives the required 90-95 % cell confluency at 24 h. For example: 
No. cells counted = 34 X 105 cells/ml 
No. cells required = 3.5 X 105 cells/well 
Require: 0.1 ml cell suspension/well 
Therefore, for 96 well plate require: 96 X 0.1 = 9.6 
To have more cell suspension, round it off to 12.0 ml 
i.e 3.5 X 105 X 12.0 ml = 1.24 
34 X 105
and: 12 1.24 = 10. 76 ml 
Therefore, to get the required number of cells per well, 1.24 ml of 34 X 105 
cells/ml was transferred to a container and diluted with 10. 76 ml of Chlamydia 
Complete media with Glucose plus Hepes (CMGH, pH 7 .5) without cycloheximide 
(Appendix 2.4). A magnetic stirrer was placed inside the suspension container 
which was in turn placed on a magnetic plate to facilitate an even distribution of 
the cell suspension. Aliquots of cell suspension (100 µI) were added to each well 
and the microtitre plates incubated at 37°C, in 5% CO2 , for 24 h. 
3.6.5.3 Titration of Inclusion Forming Units 
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After 24 h incubation, each well was inspected for confluency (90 95 % ) and 
contamination, using an inverted microscope. All contaminated or overgrown 
microtitre plates were discarded and the remaining plates, placed in the incubator 
until ready to be inoculated. 
Chlamydia stock suspensions were removed from 70°C and thawed quickly at 
37°C. The suspensions were serially diluted to the desired concentration (10°, 10-2
to 104) with sterile sucrose-phosphate glutamate (SPG). 
The microtitre plates were removed from the incubator, spent media removed with 
vacuum, and one drop ( ~ 60 µl) of CMGH medium containing NGV antibiotics 
(nystatin, 25 U/ml; gentamicin, 10 µglml; vancomycin, 25 µg/ml) and 
cycloheximide (1 mg/ml) added to the monolayer. From each dilution, 100 µI were 
added to two wells i.e in duplicates, and each plate was properly sealed before 
centrifuging at 2240 rpm for 1 h. Six isolates were inoculated per plate. After 
centrifugation, the suspensions were removed with vacuum, and 200 µI of CMGH 
(NGV and cycloheximide) were again, added to each well. Plates were incubated 
for 48 h at 37°C in 5 % CO2 • 
After 48 h, the microtitre culture plates were examined under a microscope to 
ensure infection of McCoy cells by chlamydia. Following that, spent CMGH was 
removed by vacuum carefully without disturbing the monolayer. The monolayers 
were fixed with 100% methanol for 10 min, by placing the plate on a shaker. 
Methanol was removed and the plate allowed to dry for 5 min. When dry, the 
monolayers were washed with phosphate buffered saline with 0.05% Tween 20 
(PBST) (Appendix 2.11) for 5 min. 
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Table VII Titration of C. trachomatis serovar dilutions by MIF test 
Dilution Well Objective Results 
10-2 1 xlO Dilution too high to count 
2 xlO 
10-3 1 x40 Dilution too high to count 
2 x40 
10-4 1 x40 Dilution too high to count 
2 x40 
10-s 1 x40 13, 26, 19 = 58/3 19.3 (3 = fields counted) 
2 x40 15, 18, 18 = 51/3 17.0 } average = 18.1 
10-6 1 xlO 34, 26, 31 = 91/3 = 30.3 
2 xlO 25, 27, 31 = 83/3 = 27.6 } average = 28.95 
MIF = microimmunofluorescence 
Dilutions (I 00 µ1) of each isolates (n =9) were infected in duplicates onto McCoy cell monolayers; 48 h post­
infection, chlamydia! inclusions were detected by a direct fluorescein isothiocyanate-conjugated (FITC) 
monoclonal antibody to Chlamydia lipopolysaccharide (CF-2). 
Inclusions were counted in three fields of view using x 10, x 16, and x40 objectives which have a conversion 
factor of 10, 25, and 150 respectively. 
To calculate the no. of IFU/ml: 
1) 10-5 dilution
= 18.1 x lOx 150x 105 
= 2.7 X 109
2) 10-6 dilution
= 28.95 X 10 X 10 X 106 
= 2. 9 X 109
AVERAGE = 2.8 x 109 IFU/ml in the isolate 
In the calculation: 150 and 10 = x 40 and xlO lens conversion factors 
105 and 106 = dilutions 
Factor 10 = amount plated factor i.e 1000 µ.1/ 100 µ.l 
1000 µ.1 > total volume of serial dilutions prepared for IFU titration and 
100 µ.1 > amount of inoculum added to each well 
3.6.5.4 Preparation of Chlamydial Antigen for Microtitre Typing 
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In order to determine the serotype of serovar, 5070 % cell confluency is required 
i .e approximately 1/3 of the usual number of McCoy cells per well. 
If 1. 24 ml of 34 X 105 cells/ml were used to obtain 90 95 % cell confluency by 
24 h ( 4.10.2), then to get 75 % required for typing: = > 1.2 x 75 
100 
= > 0.9 ml of cell suspension 
Therefore: Add 12 0.9 = 11. 1 ml of CMGH media to 0.9 ml of cell suspension. 
After 24 h incubation of McCoy cells in a microtitre plate, the monolayers were 
inspected for contamination and for the required 5070 % corrfluency . Spent 
medium was removed with vacuum and 10 µ.l of CMGH (containing NGV +
cycloheximide ) were added. Following that, 10 µ.l of the last dilution where the 
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IFUs were too numerous to count, in this case the dilution was 10 4 (Table VII) 
were added to the monolayers. 
Inoculated plates were centrifuged (Beckman J6-M centrifuge, 4.2 rotor) at 1.200 
x g at 37°C for 60 min. After centrifugation, the inoculum was aspirated from the 
wells, and then replaced with 200 µl of fresh medium containing 10% fetal bovine 
serum (BSA) and 1.0 µg/ml cycloheximide. This was followed by incubation at 
37°C in 5 % CO2 for 40 48 h. After incubation, spent medium was aspirated and 
the monolayers fixed with methanol for 10 min by placing the plate on a shaker, 
and then air dried (5 10 min). 
Each well was rinsed with a drop of PBST prior to adding approximately 200 µI 
of MAb-blocking and preservative (MABP) solution (2 % BSA, PBST, 0. 1 % 
sodium azide) to the fixed wells and incubating for 4 h at 37°C. At this stage, the 
plates were ready for staining and serotyping. If overnight storage was required, 
plates were held at 4°C. 
3.6.5.5 Serotyping of the Isolates by Microtitre Method 
After 4 h incubation, MABP was removed and 25 µI of the MAb dilution (12 
MAbs per row per plate) was added to the appropriate wells. Plates were agitated 
at a moderate speed on a shaker for 2 h. Thereafter, MAbs were carefully 
removed from the wells and then replaced in their original containers. Due to the 
unavailability of commercial MAbs, these MAbs had to be reused, therefore, extra 
care was taken when removing MAb from each well making sure that the correct 
MAb was placed into its correct tube. 
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The MAbs which were reacted with the fixed inclusions of each isolate, consisted 
of a panel of 17 C. trachomatis species , group , subgroup , and serovar-specific 
MAbs. The optimal titre of the MAbs for the detection of prototype strain 
inclusions had already been determined. Table VIII (Suchland and Stamm, 1991) 
shows the positions and titre of MAbs used for serotyping. This table was used as 
a guideline for determining serotypes of the isolates tested. 
Using a pasteur pipette, wells were washed 3X with PBST, followed by addition 
of 20 µI of FITC goat antimouse immunoglobulin G (lgG) to each well. Plates 
were again placed on a shaker for 30 min at room temperature to allow the 
conjugate counterstain to react. The wells were washed once with PBST and 
finally with distilled water (dH20). Plates were inverted on paper towel to remove 
excess water. One drop of FA mounting fluid (50% glycerol, 50% Tris buffer 
pH 8.5) was added to each well, and the excess was shaken off. Plates were placed 
at 4°C and read within 24 h. 
Reading was done by inverting the microtitre plates and scanning each well with 
an epifluorescence microscope (Zeiss) at xlO0 magnification with a xlO Neofluor 
lens. Wells were scored according to the intensity of fluorescence of inclusions as: 
, ±, ( + ), and +. Lack of or no fluorescence was recorded as , barely detectable 
fluorescence as ±, light fluorescence as ( +), and strong fluorescence as + . 
Serotype designation was assigned by numerically scoring positive wells and 
matching the isolate' s numerical code to the numerical code of the assigned 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.7 ANALYSIS OF DATA 
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Where required, patient data were analysed using the Chi square (X2) test with Yate's 
correction. The level of significance was set at 95% and recorded as p� 0.05. 
The Kappa (K) statistic was calculated as follows: 
K = 2 (ad be) 





This study comprised a part of the Department of Medical Microbiology's epidemiological 
survey of genital ulcer disease. The methodology used for the diagnosis of GUD other 
than LGV, are not part of this study and are therefore, not discussed. All 247 specimens 
were designated codes i.e specimen codes (P00l 045 and U00l 202) in the order of 
specimen collection and laboratory codes (randomly from 1 to infinity). This was done 
to distinguish one specimen from the other, and to avoid introduction of any form of bias 
while performing various laboratory tests. Results of different tests were recorded and 
analyzed separately. Results obtained are represented in both the specimen and laboratory 
codes. 
4.2 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF THE 
POPULATION STUDIED 
During the period 3 July 1995 to 22 August 1995, a total of 247 patients consented to 
participate in the study. They were all adult males and predominantly of African race, 
with a mean age of 25.7 (range, 15 to 54 years). The majority of the patients were 
unmarried 215 (87%). The mean age at first intercourse was 15.4 years, and the mean 
number of sexual partners in preceding 6 months was 3 (range, 1 20). Of the 247 men, 
141 (57, 1 % ) had a history of a previous STD. 
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A total of 18 (7. 3 % ) patients were circumcised. On examination of the genitalia, 91 
(37%) had single lesions and 156 (63.2%) multiple lesions. These ulcers were located on 
the penile shaft, coronal sulcus, prepuce (outside and inside), and glans. Phimosis was 
present in 26 (10.5%). Lymphadenopathy (either unilateral or bilateral) was detected in 
107 (43.3%) of the patients, 11 (4.5%) of whom had buboes. Data obtained from patients 
are depicted in Table XI. 
4.3 OVERALL LABORATORY FINDINGS 
As this study was part of a comprehensive departmental genital ulcer study, the microbial 
agents isolated from the patient population studied are presented in Table XII. The 
diagnosis of the conditions was essentially based on culture except for syphilis which was 
based on serology. Haemophilus ducreyi was the most prevalent and was isolated from 
83 (34%) of the specimens. Syphilis, defined as positive RPR and TPHA, was diagnosed 
in 70 (28.3%) patients, while genital herpes, granuloma inguinale and lymphogranuloma 
venereum (LG V) were detected in 28 (11. 3 % ) , 15 ( 6. 1 % ) and 13 ( 5. 3 % ) respectively. 
The 13 (5.3 %) which were positive for LGV are based on culture without imrnunotyping. 
In 38 (15.4%) patients, none of the diseases investigated for, were diagnosed. Mixed 
infections were detected in 35 (14.2%) of the patients, 25 of whom had syphilis. LGV 
was detected in 2 patients as a single infection and in the remaining 11, as mixed 
infections. Four of these patients were infected concurrently with syphilis, 4 with 
chancroid, and 3 with granuloma inguinale. Triple infections with syphilis, chancroid and 
granuloma inguinale were detected in 2 patients (Table XIII). 
Of the endourethral swab specimens (n =247), Neisseria gonorrhoeae was detected in 21 
(8.5%) patients by culture. A total of 128 (52.2%) patients were seropositive for human 
immunodeficiency virus (HIV). 
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Table IX Demographic, history and clinical characteristics of patients presenting with 
genital ulcers (n = 247) at the City Health STD clinic, Durban 
Characteristics Number (mean/%) 
Age in years 
Range (mean) 15-54 (25.7)
Age at first intercourse 
Range (mean) 13 21 (15 .4)
Marital status 
Single 215 (87%) 
Married 32 (13 % ) 
Sexual partners (past 6 months) 
Range (mean) 1-20 (3.0)























• 11 (4.5%) of the 107 (43.3%) patients also had buboes.
86 
Table X A breakdown of sexually transmitted diseases detected in patient population 
presenting with genital ulcers (n=247) 
Single Mixed Total 
Chancroid 62 21 83 (33.6%) 
Syphilis* 45 25 70 (28.3 %) 
Genital herpes 21 7 28 (11.3%) 
Granuloma inguinale 7 8 15 (6.1 %) 
Lymphogranuloma venereum 2 11 13 (5.3 %) 
None of the above detected - - 38 (15.4%) 
* All the above diseases but Syphilis, were detected using culture methods. Syphylis was diagnosed on the
basis of positive syphilis serology.
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Table XI Microbiological diagnosis in 35 patients with mixed infections presenting 
with genital ulcers at the City Health STD clinic, Durban 
Infections 
Double infections 
Chancroid + Syphilis 
Chancroid + Genital herpes 
Chancroid + LGV 
Granuloma inguinale + LGV 
Syphilis + Granuloma inguinale 
Syphilis + LGV 
Syphilis + Genital herpes 
Triple infections 
Syphilis + Chancroid + Granuloma inguinale 
LGV = Lymphogranuloma venereum 









Microbiological diagnosis of the diseases was based on the specimens collected from 247 patients who 
presented with genital ulcers at the City Health STD Clinic, Durban. 
4.4 GENITAL ULCER SPEC™EN RESULTS 
4.4.1 Results of C. trachomatis Culture 
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Culture of genital ulcer lesions for C. trachomatis was performed on all 247 patients; for 
the first 200 specimens, this was done within 24 hours of specimen collection and for the 
last 47 specimens, after a week of storage at 70°C. After the initial evaluation following 
48 hours incubation, C. trachomatis inclusions were detected in 10 ( 4 % ) of the specimens 
by fluorescent monoclonal antibody staining (Plate 3). No non specific clusters of 
fluorescent particles were found in these 10 and free extracellular fluorescent particles 
were seen only rarely. A further 47 (19%) of the specimens were categorised as doubtful 
because free apple green fluorescent particles could be visualised. These specimens were 
subjected to a blind passage together with the 190 (76.9%) negative specimens in which 
no inclusions were detected. 
Following blind passage and a 48 h incubation, a further 3 specimens developed the 
characteristic apple green inclusion forming units (Plate 4, 5, 6, 7). None of the clinical 
specimens which were stored at 70°C for a week prior to inoculation, produced inclusion 
bodies when evaluated initially, nor after subjection of blind passage. In total, C. 
trachomatis was successfully isolated from cell cultures in 13 (5. 3 % ) of the specimens 
tested and the remaining 234 (94. 7 % ) cultures were negative. Table XIV shows the 
number of inclusions recorded per positive sample. 
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Table XII Number of inclusion forming units (IFU) per coverslip from cycloheximide­



































Cultures grown on coverslips were fixed with methanol and stained with fluorescein-labeled monoclonal 
antibodies specific for C. trachomatis detection. 
• Inclusions per coverslip were counted 48 h (first passage) and 72-96 h (second passage) post-infection.







4.4.2 Results of Specific Amplification of Cryptic Plasmid and MOMP Genes by PCR 
4.4.2.1 PCR Sensitivity using C. trachomatis L2 DNA 
Initial experiments were performed on the positive control, C. trachomatis L2 DNA (from 
University of Washington, Seattle) with the two primer sets (plasmid and MOMP) at 
annealing temperatures of 67° and 55°C, respectively. Serial dilutions of 10·2 to 10- 10 were
prepared and the resulting amplified products were analysed on a 1. 5 % agarose gel stained 
ethidium bromide. As anticipated, using primers for the cryptic plasmid and MOMP 
genes, a 452 base pair (bp) and 1128 bp product was amplified respectively. Higher 
sensitivity was obtained with primers for the endogenous plasmid (1Q· 10 dilution) as 
compared to the MOMP gene (10·7) of C. trachomatis L2 DNA (Plate 8).
4.4.2.2 PCR with culture-positive and -negative material 
The 24 7 genital ulcer patient specimens cultured onto McCoy cell monolayers were used 
as templates for amplification of the endogenous plasmid by PCR. All 13 genital ulcer 
specimens which successfully infected McCoy cells also yielded the 452 bp product after 
amplification of the endogenous plasmid DNA by PCR (Plate 9), while only 10 yielded 
the 1128 bp product specific for the MOMP gene (Plate 10). The intensity of the 452 bp 
product decreased with decreasing numbers of IFU of the culture sample and the 
corresponding ethidium bromide stained gel is shown in Plate 10. The results are 
summarized in Table XIII. 
When the 234 samples that were negative by culture were subjected to specific 
amplification of the cryptic plasmid gene, the expected 452 bp fragment was obtained in 
42 (17%) (Plate 11 and 12). Sixteen (38%) of the samples (n=42) yielded products 
specific for the MOMP gene. The remaining 26 samples which were negative by culture 
yielded notably weak signals in the specific amplification of the weak plasmid gene. 
96 
Hence, overall, specific amplification of the 452 bp product of the C. trachomatis cryptic 
plasmid DNA by PCR was detected in 55 (22.3%) of the samples as compared to 26 
(10.5 %) for the 1128 bp of the MOMP gene. 
As culture and PCR (using primers specific for amplification of endogenous plasmid gene) 
were used to diagnose C. trachomatis in 247 genital ulcer specimens collected, comparison 
of the results obtained by the two techniques are shown in Table XIV. Both tests together, 
detected C. trachomatis in 55 (22.3%) specimens. Culture was unable to detect 42 
(17.0%) of the specimens that were detected by PCR. There were 13 (5.3%) true 
positives and 192 (77.7%) true negatives. As suggested by other workers, PCR and 
culture were considered as an expanded gold standard and the former had a 100% 
detection rate while culture detected 25 % of the infections. To measure the agreement 
between PCR and culture results, Kappa statistic (K) was calculated; it was found to be 






Table XIII Detection of C. trachomatis in culture-positive specimens (n = 13), 
by PCR with primers for the specific amplification of the MOMP and the 
endogenous plasmid genes 
Specimen PCR results 
Number 
Plasmid Gene 
P 010* ± 
U 144* ± 
U 149* ± 
U 041 + 
P 016 + 
P 039 + 
U 113 + 
U 119 + 
U 128 + 
P 042 + 
U 145 + 
U 090 + 
U 135 + 
PCR, polymerase chain reaction 















±, represents weakly positive products at gel level; +, positive; -, negative. 
* Specimen positive on sub-culture only.
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Table XIV Comparison of cell culture and PCR for the detection of C. trachomatis
in genital ulcer samples (n = 247) 
PCR 
CULTURE POSITIVE NEGATIVE TOTAL 
POSITIVE 13 0 13 
NEGATIVE 42 192 234 
TOTAL 55 192 247 
PCR, polymerase chain reaction 
Results of PCR with plasmid primers carried out on culture samples 
When specific amplification of the cryptic plasmid gene by PCR and culture used as an expanded gold 
standard for detection of C. trachomatis in genital ulcer spedmt:ns, the former had a 100.0% detection rate 
while the latter had 25 % . Kappa statistic (K) = 0.485 
4.4.3 Results of Microtitre Typing of Chlamydial Isolates 
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The 13 culture positive samples which had been stored were revived on McCoy cell lines 
for immunotyping by the micro immunofluorescence (MIF) test. In 7 of the samples 
viable organisms were recovered after initial isolation and two further isolates were 
recovered after 3 passages. The remaining 4 samples were not recoverable and MIF could 
not be performed as viability is neccesary for titration and serotyping. These 4 isolates 
are assumed to have died during storage and transport. Titres varying from 1.4 x 103 to 
5. 3 x 106 were obtained for the nine viable isolates as shown in Table XV. Inclusion
forming units (ifu) in dilutions higher than 10-3, were not detected in most of the isolates. 
Serotyping was performed on the 9 recoverable culture positive clinical isolates. The titre 
used in the serotyping, was the one that gave countable numbers of inclusions i.e the 
highest dilution appearing in Table XV for each of the samples tested. Table VIII. in 
Chapter 3, was used as a guideline in determining the serovars of the group of chlamydia! 
strains characterized. Serovar designations were compared once all the isolates (n =9) 
(inclusive of those that had to undergo 3 passages prior to the test) had been completely 
typed. A positive MAb LV 22 reaction was included in the test to verify growth of isolate 
(which were used as antigens) on the microtitre plate and also, as a measure of 
confirmation that the strain being tested does indeed belong to the species C. trachomatis.
The reaction patterns of the monoclonal antibodies (MAbs) against the 9 chlamydia! strains 
are represented in Table XVI. All the 9 isolates reacted with the C. trachomatis species
specific MAB L V 22 ( well 1). Strong fluorescence ( +) was given by all isolates but two. 
MAbs LL-33 (well 2) and GG 11 (well 3) reacted only with the two strains designated as 
la, while KB 8 (well 9) was common to sample 1, 8, and 9 designated as serovars Ll and 
E. Well 4 (BB-11), well 7 (LV 23/LA 10) and well 8 (LV-27/CC 1), distinguished the
L2 strains from the others. Mab KB 8 (well 9) reacted strongly with serovars Ll and E. 
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Of the infecting isolates, 7 belonged to the B complex [serovar Ll, 1 (11.1 % ) ; serovar L2, 
4 (44.4%); serovar E, 2 (22.2%)], and 2 belonged to the C complex (serovar Ia, 2). Five 
of the isolates characterized, belonged to the lymphogranuloma venereum (LGV) biovar 
(1 of Ll, 4 of L2). Table XVII shows specimen and sample numbers with the 
corresponding serovars. 
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Table XV Titration of chlamydia strains in the micro-immunofluorescence test 
Sample Dilutions Titre 
Number Results 
101 10 2 10-3
1 TNTC 5.25 X 106 5.33 X 106 5.29 X 106
2 7.8 X 104 3.4 X 105 TFTC 2.1 X 105
3 6.73 X 104 TFTC TFTC 6.73 X 104
4 2.06 X 105 TFTC TFTC 2.06 X 105
5 1.0 X 105 4.75 X 105 1.25 X 106 6.08 X 105
6 1.4 X 103 TFTC TFTC 1.4 X 103
7 TNTC 1.13 X 106 1.33 X 106 1.23 X 106
8 N/D N/D N/D N/D 
9 N/D N/D N/D N/D 
10 N/D N/D N/D N/D 
11 N/D N/D N/D N/D 
12 3.08 X 103 TFTC N/D 4.47 X 104
13 3.08 X 104 1.08 X 105 TFTC 6.94 X 104
TNTC: too numerous to count; TFTC: too few to count; N/D: not done 
This table shows the results of the three dilutions as these were suitable for serotyping. 
- -Table XVI Microtitre serotyping monoclonal antibody (MAb) reaction patterns and scoring scheme for Chlamydia trachomatis culture positive specimens 
lmmunofluorescent Reaction' with C. trachomatis genital ulcer strains 
I 2 3 4 5 6 7 8 
Specimen (LV-22 (LL 33 (GG-11 (BB-I I (BB-3 (DP-I/ (LV-23/ (LV-27/ 
No: [I :401) (I :301) (1 :301) I I :401) /PE-5 AC-I I LA-10 CC-I
[I :401) [1:401) [I :401) [I :401) 
I + + (+) 
2 + + + + 
3 + + + + 
4 + + (+) + + 
5 + + + + 
6 + + + + + 
7 + + + 
8 + + + + + 
9 + + + 
• +, bright fluorescence; (+) light fluorescence; blank square, no reaction.
• Titres and serovars are designated numerically and alphabetically.
Light type indicates a light-staining fluorescence reaction, and bold type indicates a strong fluorescence reaction.









[I :401) KK-1 
I I :401) 
+ 
The MAbs reacted with fixed inclusions of each isolate consisted of a panel of 17 C. trachomatis species-, group-, subgroup-, and serovar specific MAbs. 
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(FC-2 


























Table XVII Results of serotyping of the C. trachomatis isolates (n = 9) by 

































Only 9 of the 13 culture-positive isolates survived shipment to University of Washington, Seattle. 
· determined by MIF test
5 isolates belonged to the LGV biovar (l of Ll, 4 of L2)
4.5 RESULTS OF ENDOURETHRAL SPECIMENS 
4.5.1 Chlamydial Antigen Detection By Direct Immunofluorescence (DIF) Test 
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Endourethral swab specimens for direct chlamydia! antigen testing were obtained from 230 
of the 24 7 patients recruited. The remaining 17 patients had severe phimosis which made 
it difficult to collect endourethral swab specimens. All 230 endourethral swab specimens 
obtained were evaluated by DIF, 36 (15.6%) were positive on first reading. A further 11 
specimens showed non specific flourescence and were re evaluated. All 11 were found 
to be negative when compared with the positive control which had been tested in parallel 
with the specimens. Most of the C. trachomatis positive slides demonstrated a 
considerable number of fluorescent elementary bodies (EBs) and the number of EBs for 
every positive slide was recorded. 
The majority of the DIF specimen smears (n=24) had EBs in the range of 2 15, while 10 
had EBs in the 11 50 range, and only 2 smears had between 51 and 100 EBs. There were 
no slide smears with 2. 100 EBs (Plate 13). 
4.5.2 Results Of Ligase Chain Reaction (LCR) Testing 
First catch urine specimens were obtained from all 247 patients and were stored at 20°C 
until testing. All urine specimens were tested in January 1996. Reactions were read the 
day following the LCR procedure. One specimen gave an invalid reading due to an air 
bubble and had to be repeated. A reading above the cut off value (positive determining 
factor) was recorded in 46 of the 247 specimens tested; thus LCR on first catch urine 
samples detected chlamydia! DNA in 18.6% of patients. 
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Comparison of the results obtained by DIF and LCR was done for the reciprocal 230 
endourethral swab specimens and first catch urine specimens (shown in Table XVIII). 
Twenty three (10%) specimens were positive by both DIF and LCR, an additional 13 
(5.65%) were detected by DIF only, while 18 (7.83%) were positive by LCR only. When 
DIF and LCR are taken as the expanded gold standard for the detection of chlamydia! 
urethritis in the 230 specimens tested, DIF and LCR had a successfull detection rates of 
66.6% and 75.9%, respectively. 
4.6 COMPARISON OF ULCER AND ENDOURETHRAL SPECIMEN RESULTS 
The use of culture on genital ulcer specimens yielded 13 isolates. A comparison of 
antigen detecting tests and molecular techniques was made. Of the 13 specimens which 
were positive by culture, 4 (30.7%) were positive by all techniques viz. DIF, PCR, LCR 
and culture; all by both culture and PCR; 6 by all three tests viz. culture, LCR, and PCR. 
None of the culture positive specimens were negative by the other three tests (PCR, LCR, 
and DIF). The results are summarized in Table XIX. 
The urethra was considered to be infected by C. trachomatis when specimens were positive 
by either DIF and/or LCR tests. An ulcer was considered to be infected by when 
specimens were positive by culture and/or PCR. Twenty four (44.4%) of the 55 genital 
ulcer specimens from which C. trachomatis was detected, had concurrent urethral 
colonisation. Fourteen (25.5%) of the above 24 were positive by DIF only, 19 (34.5%) 
by LCR only, while 31 (56.4%) were negative by both techniques. Four patients had 
phimosis and endourethral swab specimens were not obtained; of these, 1 was positive by 
LCR. Two of the 5 patients with ulcers, who had proven L strains immunotyped by the 
MIF test, also had Chlamydia in the urethra confirmed by DIF and LCR. Three of the 
4 patients with ulcers from whom non LGV strains were isolated, also had Chlamydia in 
the urethra. The results are shown in Table XX. 
112 
Comparison of the results obtained in the two categories (ulcer and urethritis), are shown 
in Table XXI. Of the 193 patients that did not have Chlamydia in their urethral 
specimens, 16.1 % had C. trachomatis in the ulcers. Twenty four (44.4%) of the 54 
patients in whom the urethra was infected, had C. trachomatis was also cultured from their 
ulcer specimens. The significant association (p value) and the relative risk (RR) between 
genital ulcer and urethritis was found to be 0.001 and 2. 75, respectively. This means that 
patients who had either urethritis or genital ulcers are more likely to be positive for the 
other, and that patients with urethritis are 2. 75 times more likely to have genital ulcers 
than those patients who did not have urethritis. 
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Table XVIII Comparison of DIF and LCR for the detection of C. trachomatis in 





DIF, direct immunofluorescence 






DIF and LCR had detection rates of 66.6% and 75.9%, n:spectively. Results are based on the urines and 
endourethral swab smears of the patients from whom, both specimens were collected. The number excludes 
the 17 patients who had phimosis and on whom, endourethral swab specimens could not be collected. 
Table XIX Analysis of results of culture, DIF, LCR, and amplified 
endogenous plasmid DNA by PCR, on culture positive samples (n=13) 
for the detection of C. trachomatis
Specimen DIF Culture 
No. 
P0lO - + 
P 016 + + 
P 039 - + 
P 042 - + 
U041 + + 
U 090 + + 
U 113 - + 
U 119 - + 
U 128 - + 
U 135 - + 
U 143 + + 
U 145 + + 
U 149 - + 
DIF, direct immunofluorescence 
LCR, ligase chain reaction 

















DIF and LCR carried out on urine and endourethral swab specimens, respectively.
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Table XX Concurrent urethral colonisation in patients presenting with genital ulcer(s) 
in which C. trachomatis was detected (n = 55) 
Patient Ulcer Urethritis Patient Ulcer Urethritis 
No. 
Cult/PCR DIF LCR 
No. 
Cult/PCR DIF LCR 
P 001 + - - U 103 + + -
P 010 + - - U 107 + + + 
P 015 + - + U 113* + - -
p 0163 + + + U 119* + - -
P 034 + - + U 121 + - -
P 039* + - + U 128b + - -
p 0423 + - + U 130 + - -
U 027 + + + U 135* + - -
U 037 + - - U 136 + - -
U 041* + + + U 138 + - -
U 048 + - - U 142 + - -
U 050 + + - U 143 + + -
U 057 + - + U 145 + + + 
U 067 + - - U 149 + - -
U 083 + - - U 159 + - + 
U 084 + PH - U 161 + - -
U 090b + + + U 162 + - -
U 096 + + + U 163 + - -
U 097 + + + U 165 + - -
Table XX continued 
Patient Ulcer Urethritis 
No. 
Cult/PCR DIF LCR 
U 166 + - -
U 170 + - -
U 174 + - +
U 175 + - +
U 176 + - + 
U 178 + PH -
U 183 + + + 
U 185 + PH -
U 188 + - -
U 191 + + -
U 193 + PH + 
U 194 + + -
U 196 + - -
U 198 + - -
U 199 + - -
U 200 + - -
U 202 + - -
+, positive;-, negative. 
PH = Phimosis (endourethral swab specimens were not collected). 
PCR, polymerase chain reaction (carried out on culture specimens). 
LCR, ligase chain reaction (performed on first void urine samples). 
DIF, direct immunofluorescence (performed on endourethral swab specimens). 
• LGV biovar strains ( I of LI, 4 of L2); a.b oculogenital strains (3 2 of E, b 2 of Ia).
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Table XXI The association of C. trachomatis detection in genital ulcer and 





POSITIVE NEGATIVE TOTAL 
POSITIVE 24 30 54 
NEGATIVE 31 162 193 
TOTAL 55 192 247 
PCR, polymerase chain reaction (results based on specific amplification of the 452 bp 
product of the endogenous plasmid DNA from culture-positive samples). 
DIF, direct immunofluorescence 
LCR, ligase chain reaction 
• DIF and LCR used as expanded gold standard for the detection of C. trachomatis from endourethral
specimens. Positive identification made when specimen was positive by either or both tests.
b PCR and culture used as expanded gold standard for the detection of C. trachomatis from genital ulcer 
specimens. Positive identification made when specimen positive by either or both tests. 
P-value = 0.001; relative risk= 2.75
CHAPTER 5 
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DISCUSSION AND CONCLUSION 
This cross sectional study was part of a comprehensive departmental genital ulcer survey, 
which was performed in order to establish the prevalence of genital ulcer diseases (GUD) 
in patients attending the City Health STD clinic in Durban. This project sought to detect 
the common aetiological conditions associated with GUD viz. chancroid, lymphogranuloma 
venereum (LGV), syphilis, granuloma inguinale and genital herpes. It was shown that 
chancroid was the most prevalent at 34% (n=83), with syphilis being the second 
commonest at 28.3 % (n=70). These findings are consistent with what is reported from 
most developing countries and furthermore, are in agreement with studies performed in 
South Africa, where chancroid and syphilis were ranked as the two most prevalent GUD 
(Crewe Brown et al, 1982; Coovadia et al, 1985; O'Farell et al, 1991; O'Farell et al, 
1994). As expected, conditions such as genital herpes and granuloma inguinale were 
detected less frequently i.e in 28 (11.3 % ) and 15 (6.1 % ) patients respectively. Concurrent 
infections were diagnosed in 35 (14.2%) of the patients, 25 of whom had syphilis. Triple 
infections were detected in only 2 patients and in both, syphilis, chancroid and granuloma 
inguinale were diagnosed. This high prevalence of mixed infections has implications for 
choosing antimicrobial therapy. 
A large study population (247 subjects) was enrolled for this study. This number allowed 
for appropriate laboratory analysis for determining the aetiology of GUD and compares 
favourably with other studies of this nature in South Africa (Crewe Brown et al, 1982; 
Coovadia et al, 1985; O'Farell et al, 1991; O'Farell et al, 1994). The latter studies 
reported sample sizes of only 100 patients. 
The high prevalence of STDs in developing countries has been attributed to a number of 
factors. In this study, most patients were unmarried men and this may reflect the greater 
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promiscuity of single men, as well as the socio economic class, because in the African 
culture, a man needs to pay a bride price (lobola) which is likely to be beyond the reach 
of men attending this type of clinic. The age at first intercourse was low and the reasons 
are largely unknown and not within the scope of this study. The mean number of sexual 
partners in the preceding 6 months was 3, which is surprisingly low. In a study of 
urethral discharge conducted ten months earlier at the same STD clinic, the mean number 
of sexual partners was found to be 8 (Small and Maleka, unpublished data). This 
difference is unlikely to be due to the difference in behaviour, as both studies looked at 
the same population and were conducted within the same time frame. One explanation 
could be that urethritis patients mainly spread their STD organism through sexual 
networking while, ulcer patients attend to commercial sex workers (CSW). However, in 
an area that is highly endemic for both syndromes, it is unlikely that the organisms would 
be distributed differently within sub-populations. It could also be related to a possible 
difference in infectivity of the microbes. This would mean that urethritis organisms would 
be less infective than the microbes that cause genital ulcers. Another reason for this lower 
figure in ulcer patients could be the difference in health seeking behaviour, as those with 
genital ulcers might tend to seek medical help much quicker compared to those with 
urethritis. The fact that more than half of the patients had a history of a previous STD 
could reflect the failure of the health services in implementing preventative strategies. 
Clinical findings in the patients were consistent with typical genital ulcer patients and there 
was nothing exceptional noted. Circumcision was noted in a low percentage of patients 
(7. 3 % ) and this is consistent with previous studies done in Durban which have also shown 
low rates of circumcision (Coovadia et al, 1985; O'Farell et al, 1991). This reflects Zulu 
custom in that it is not part of the tradition for men to undergo circumcision. Our findings 
are in contrast with other African studies such as in Ghana (Mabey et al, 1987) where 
98.1 % were circumcised. As it is generally accepted that minor trauma is essential in the 
pathogenesis of GUD, it has been hypothesised that uncircumcised as compared to 
circumcised men develop ulcers more frequently. There was no significant difference in 
clinical findings between the chlamydia negative and positive patients. This is expected 
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as it is well known that the clinical features of genital ulcers cannot be used to make a 
microbial aetiological diagnosis (von Zeissl, 1882; cited by: Sturm 1981; Sturm et al, 
1987). 
The diagnosis of the ulcerative condition LGV, was based on the expanded reference 
standard of positive cell culture and PCR. The specimens were centrifuged onto McCoy 
cell monolayers pretreated with cycloheximide to enhance the efficiency of infection. 
Samples that were positive by culture were immunotyped by the microimmunofluorescence 
(MIF) test. For molecular analysis, DNA was extracted from C. trachomatis infected and 
uninfected McCoy cells by the classical phenol/chloroform extraction method (Peterson et 
al, 1989; Sambrook et al, 1989). The DNA extracts were subjected to specific 
amplification of the C. trachomatis plasmid gene by PCR and those which yielded a 452 
bp band were further subjected to specific amplification of the major outer membrane 
protein (MOMP) gene. Immunotyping revealed L-strains (Ll and L2) which cause LGV, 
as well as non-LGV strains i.e the oculogenital strains (D to K) responsible for urethritis 
and other genital infections. Possible explanation for the isolation of these oculogenital 
strains in the ulcer specimens could be that these strains do somehow cause LGV or that 
there was contamination of the ulcers from a subclinical urethral infection. 
The use of currently available diagnostic technology (explained above) showed a 
prevalence of 22.3% for C. trachomatis in ulcer specimens. This figure for LGV is 
markedly increased from previous studies in Durban, which were restricted in their 
diagnostic methods. This figure is similar to the 24 % reported for Madagascar (Harms 
et al, 1994), but is considerably higher than the 7% reported in The Gambia (Mabey et 
al, 1987), 0.55% in Nigeria (Ghatak, 1992), and 8% in Zimbabwe (Tswana et al, 1995). 
Only Mabey et al (The Gambia, 1987) cultured the specimens on McCoy cells and found 
a prevalence percentage which is comparable with ours by means of culture. Harms et al 
(Madagascar, 1994) and Ghatak et al (Nigeria, 1992), used direct immunofluorescence test 
(MicroTrak, Syva) to diagnose C. trachomatis, while Tswana et al (Zimbabwe, 1995) used 
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Chlamydiazyme test (Abbott Diagnostics) for Chlamydia detection. Due to the different 
methodology employed in all five studies, comparison and interpretation of the results are 
difficult. However, the similarity between the culture results from The Gambia and this 
study suggests similar prevalence rates. 
Using culture alone, 5.3% of the LGV infections were detected in the specimens obtained 
from genital ulcers. Previous studies done in Durban have shown rates of chlamydia! 
(LGV) infection of 1 %, 7%, and 1.5% by Coovadia et al (1985), O'Farell et al (1991), 
and O'Farell et al (1994), respectively. The first study used clinical criteria only, while 
the latter studies used direct immunofluorescence (DIF) for the detection of chlamydia! 
antigen in ulcer exudates. These figures are in sharp contrast to those obtained in this 
study and show the obvious problems related to difference in methodology. 
The use of molecular methodology which was previously unavailable, does improve 
detection. However, if the increase in chlamydia! infection is not only due to improved 
diagnostic techniques, one could speculate that improved access to health care facilities and 
subsequent antibiotic therapy that does not cover chlamydia, may account for some of the 
increase in prevalence of chlamydia) infections. Future studies using the more advanced 
techniques employed in this study will most likely shed more light on the trends in GUD 
including those caused by C. trachomatis (Ll-3) in this population. 
Although culture is considered the gold standard in chlamydia diagnosis despite its relative 
low level of sensitivity (Leonardi et al, 1992; Bass et al, 1993; Chernesky et al, 1994; 
Schachter et al, 1994; Thejls et al, 1994), there were still a large number of false 
negatives in this study when compared to molecular techniques. This is in accordance with 
recent studies performed for the diagnosis of urethritis with other amplification techniques 
or studies that used multiple immunoassays in which it was suggested that culture as the 
gold standard may have a sensitivity of only 55 to 65 % (Leonardi et al, 1992; Bass et al, 
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1993; Chernesky et al, 1994; Schachter et al, 1994; Thejls et al, 1994). For the diagnosis 
of LGV, this low sensitivity of culture creates a problem of interpretation because 
presently, culture is the only technique by which typing can be done. The possibility of 
the use of amplification techniques with subsequent utilisation of restriction enzymes may 
offer an alternative for detecting different strains. 
The factors that could lead to false negative Chlamydia cultures are inadequate specimen 
collection, transportation of the specimens to the laboratory, and delay in processing of the 
specimens (Mardh et al, 1981; Kuo et al, 1983). In our case, false negativity in cultures 
could have been due to transportation of specimens at room temperature instead of 4°C, 
a factor that is known to reduce the sensitivity of the cell culture assay. For maximal 
results, it is imperative that adequate specimens be collected, and since the object is to 
obtain a representative sample of epithelial cells, it is recommended that the specimens be 
collected with some vigour either by swabbing or scraping. Swabbing, however, is the 
method advised by the Centers for Disease Control and Prevention (CDC) for the 
collection of chlamydia specimen using dacron swabs on metal or plastic shafts 
recommended for recovery of this fastidious organism (Mardh and Zeeberg, 1981; CDC, 
1993). In this instance, vigorous scraping under the edges of the ulcer(s) was done using 
a disposable plastic loop so as not to subject patients to multiple sampling for our 
comprehensive study. Furthermore, owing to the painful nature of most ulcer(s), the yield 
of the material in subsequent scrapings is likely to be compromised. 
In this study, a suspension of ulcer scraping was made in 0.5 ml of phosphate buffered 
saline (PBS) before being aliquoted (100 µI) into various transport media (2 3 h after 
collection) for the isolation of the microorganisms. Although the specimen collection 
procedure was patient friendly and solved the problem of sequence sampling for the 
different techniques, it could however, have compromised the yield as far as chlamydia 
cultures are concerned. Preserving chlamydia! infectivity in a clinical specimen is the 
obvious prerequisite for successful culture diagnosis, and thus, the use of PBS and not 
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direct inoculation into chlamydia transport medium (CTM), could have contributed to the 
low yield in culture and hence, the high positive rate when using amplification of plasmid 
DNA by PCR. The considerable variation of chlamydial strains in their infectivity for cell 
culture could also explain the successful isolation of some specimens; notably LGV strains 
grow much easier than the oculogenital strains (Schachter and Wyrick, 1994). Therefore, 
in view of the above statement, specimens in this study which were negative by culture but 
positive by PCR, could reflect the presence of the latter. 
The 50 specimens which were processed a week after sampling (due to excessive workload 
which had accumulated from the first 200 specimens) and after being stored in transport 
media at 70°C, were all negative by culture. This may have been due to death of the 
organisms during storage, which could have been aggravated by specimen transportation 
at room temperature prior to storage. The recommendation that specimens be stored at 
70°C if delay in inoculation is expected stems from the knowledge that the viability of any 
chlamydiae present is quickly lost upon storage at 70°C or if the specimen is kept for 
more than 24 h at 4°C. This is substantiated by the existence of various reports on the 
reduction of chlamydial infectivity after a freeze-thaw cycle. The ability of PCR for the 
specific amplification of the endogenous plasmid gene to detect Chlamydia in 22 of the last 
50 samples, could possibly be that storage at 70°C may have resulted in the rupturing of 
the membranes of Chlamydia organisms and release of the DNA, therefore, enhancing 
their detection by PCR. This however, is only speculative. The problems encountered 
highlight the difficulties in collecting specimens from subjects for which various fastidious 
organisms are to be cultured from the same specimen. Adequate pre planning of the 
method of collection and processing is essential to ensure the optimal isolation of all 
organisms sought. 
The culture procedure employed, was similar to that used by many other laboratories. By 
using tissue culture technique, C. trachomatis was successfully cultured from 13 (5. 3 % ) 
of the 247 specimens collected. Ten specimens were positive on initial isolation and a 
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further 3 specimens became positive after a second passage. Initial cultures of the latter, 
did show extracellular fluorescing particles suggesting EB release. Therefore, the reason 
for the increase in the number of positive specimens after a blind passage, was likely not 
due to the fact that multiple passaging increases chlamydia! recovery, but because the 
specimens were originally positive and that the Chlamydia replication cycle could have 
been longer than 48 h. Extracellular EBs cannot positively be identified as such. Another 
reason could be that the specimens had low copy number of infectious particles which 
could have been aggravated by the inoculation of most or all the infectious particles into 
the second track vial (culture done in duplicates), thereby giving a negative result upon 
staining. Since different isolates may have slightly different growth rates, any set 
incubation time is a compromise. A single blind passage was undertaken on initial 
negative culture as further passaging does not increase the number of positives (Schachter 
and Martin 1987). 
The high number of inclusions ( > 200) in the cultures which were initially positive 
reflects the bacterial load in these specimens and it indicates that getting adequate 
specimens can increase the positivity rate. It is possible that if the study was only done 
for the detection of chlamydia! infection, the positive yield of cultures would have been 
greater as the procedures followed in this study could have compromised the chlamydia 
culture. 
For improving the detection of chlamydiae in specimens which were either positive or 
negative by culture, DNA extracts from all 247 specimens were subjected to specific 
amplification of the endogenous plasmid by PCR. A 452 bp fragment was obtained from 
55/247 (22.3%) specimens [i.e all 13 (5.3%) specimens positive by culture plus an 
additional 42 (17%) specimens negative by culture. The reason for the higher sensitivity 
by PCR of plasmid DNA compared to culture may be that non viable chlamydiae were 
present in the samples, or that the chlamydiae in the sample, were in their reticulate body 
state which can be detected by PCR and not by tissue culture, as they are non infectious. 
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A second PCR assay using primer pair oDVDIV and o5'MOMP specific for the 
amplification of the MOMP gene (Lampe et al, 1993), was employed to compare its 
sensitivity to plasmid DNA by PCR. Only 26 (47.3%) of the 55 samples yielded products 
specific for the MOMP gene. About 27% of the samples in which no amplified products 
were obtained for the MOMP gene, corresponded to those yielding weak signals in the 
specific amplification of the endogenous cryptic plasmid DNA by PCR. Comparison of 
PCR with the different primer sets on the 13 culture positive samples especially those with 
< 10 IFU, showed the plasmid primer set to be the most sensitive. This is in accordance 
with the results obtained on the sensitivity of the test performed on the prepared dilution 
series of C. trachomatis L2 DNA. Specific amplification by PCR of L2 DNA was a 
thousand fold less sensitive using primers for the MOMP gene as compared to the 
endogenous plasmid. This can be explained by the presence of multiple copies of plasmid 
in each chlamydial cell, as serovar L2 contains 10 plasmid copies per chromosomal DNA 
equivalent (Palmer and Falkow, 1986). 
Several investigators have determined the sensitivity of the PCR in a model system. 
Purified elementary bodies (EBs) were used in all instances, and one copy of target DNA 
could be detected by specific amplification of both the MOMP gene (Palmer et al, 1991) 
and the plasmid gene (Ostergaard et al, 1990). However, results in this study are based 
on the infectivity of C. trachomatis serovar L2 in McCoy cells, and are therefore, more 
closely related to the clinical situation. 
Comparison of DNA based methods (using C. trachomatis plasmid and MOMP genes) 
with culture has been reported by several workers. Claas et al (1990), reported 26/156 
urethral samples to be positive by culture. These 26 samples and an additional two, gave 
positive results with primers specific for the amplification of both the plasmid and 
ribosomal DNA by PCR. In a study by Holland et al (1990), 14 cervical samples were 
tested, two of which were weakly positive, five strongly positive, and seven negative in 
culture. The weakly positive samples gave visible bands in gels only after specific 
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amplification of the MOMP gene by PCR, and the culture negative samples remained 
negative. Bobo et al (1990), cultured 104 cervical samples and all the 46 culture positive 
samples were found to be positive by PCR with primers for the specific amplification of 
the MOMP gene. Ostergaard et al (1990), tested 223 clinical samples (endourethral, 
endocervix and conjunctiva!), of which 26 were positive by culture. These and 14 culture
negative samples gave positive results after amplification of plasmid DNA by PCR. Of 
the culture negative samples, 12 (86%) were confirmed as positive by ELISA (IDEIA, 
Boots Celltech). None of these authors, except Bobo et al (1990), report on the number 
of inclusion forming units (IFU) of C. trachomatis in the patient samples. This study has 
shown that PCR assays (depending on the primer set used) can give negative results on 
samples that are weakly positive ( < 10 ifu) by culture for C. trachomatis (L2 strain). 
Results of this study with regard to the sensitivity of PCR, corroborate findings by others 
(Mahony et al, 1993; Loeffelholtz et al, 1992; Ossewaarde et al, 1992) although different 
primers were used from the ones in this study, these workers have shown that specific 
amplification of the plasmid DNA by PCR was more sensitive than that of the 
chromosomal DNA, detecting up to 25 % more positives. In contrast, Bobo et al (1990) 
found all the weakly culture positive samples to be positive following amplification of the 
MOMP gene by PCR. This group used primers for the specific amplification of the 
MOMP gene by PCR only, and therefore, no conclusions can be drawn about the relative 
sensitivity of this PCR in comparison with that of specific amplification of the plasmid 
gene. 
Comparison of the detection of C. trachomatis by culture and that of specific amplification 
of the plasmid gene in genital ulcer specimens, the Kappa (K) statistic (0.485) revealed a 
moderate agreement. Specific amplification of plasmid DNA by PCR and culture (either 
singly or combined), managed to detect C. trachomatis in 55 (22.3%) of the samples. 
Culture was unable to detect 42 (17 % ) of the samples detected by PCR. Between the two 
tests, 13 (5.3%) were true positives while, 192 (77.7%) were true negatives. 
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Although culture is the II gold standard 11, this study where the detection rate of 25 % was 
observed, emphasizes the fact like elsewhere, that culture has a sensitivity of up to 55 to 
65% (Leonardi et al, 1992; Bass et al, 1993; Chernesky et al, 1994; Schachter et al, 
1994; Thejls et al, 1994). 
Of the 13 culture positive specimens which were to be immunotyped using micro
immunofluorescence (MIF), 4 were lost during storage and/or transport, the major factor 
being a breakdown of the 70°C freezer. In keeping with the typical LGV serovars 5/9 
of the strains were of the LGV biovar. Two of the isolates belonged to the recently 
described serovar Ia and these together with the two E serovar isolates represent non LGV 
isolates. This is the first time that the serovars L2, E and Ia have been reported from 
South Africa. In keeping with the predominance of B complex isolates worldwide, this 
study confirmed this, as 77.7% of the isolates were of class B. The dominance of class 
B isolates (L2, L2a, E, D, Da, B, Ba) may indicate some biological advantage over other 
serovars. 
Only one of the strains belonged to the Ll serovar which was the predominant serovar in 
the only other South African study which used MIF. In the study reported by Hayes et 
al (1994), 18 isolates were characterised by MIF, of which 11 (61 %) belonged to the Ll 
serovar and the remaining 7 (39%) showed no reaction. In Durban, a far greater variety 
of serovars was found and this would indicate the circulation of many different strains 
within the community as opposed to fewer strains in the Johannesburg study. This may 
indicate a more endemic pattern of spread in Durban as opposed to a possible epidemic 
spread of single strains in Johannesburg. 
Endourethral swab specimens and first void urine (FVU) specimens were collected for the 
diagnosis of concurrent urethral infection. Chlamydia! antigen detection was performed 
on endourethral swab specimens by direct immunofluorescence (DIF) using MicroTrak 
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slides (MicroTrak, Syva). This test uses species specific monoclonal antibodies that bind 
to MOMP. A molecular technique, a plasmid based ligase chain reaction (LCR) was used 
on the FVU specimens. Studies done worldwide, as well as those done in South Africa, 
have employed a variety of diagnostic tools for the detection of C. trachomatis urethritis. 
Almost all studies have used tissue culture together with other tests such as the DIP 
antibody test, enzyme immunoassays (EIAs), serology, and LCR (Alexander et al, 1985, 
Bentsi et al, 1985; Stamm and Mardh, 1990; Bassiri et al, 1995; Van der Pol et al, 1995). 
Pham Kanter et al (1996), have summarized all the results of studies conducted in South 
Africa and various tests used in the diagnosis of chlamydia! urethritis. They reported C. 
trachomatis to be responsible for 30 40% of non gonococcal urethritis (NGU). 
Of the 247 patients recruited, DIF was performed on 230 endourethral specimens thereof. 
In the remaining 17 patients, it was not possible to perform DIF as the patients had 
phimosis and endourethral swab specimens were unohtainable. This is a problem when 
testing for chlamydia! infection with DIF alone as can be seen in this study where 5 of the 
17 patients (29 .4 % ) with phimosis were positive by LCR. The positive signal in the 5 
urine specimens, could be due to the Chlamydia originating from either the urethra or 
intraprepusal ulcers. Thirty six of the 230 (15. 6 % ) urethral specimens obtained, had the 
characteristic fluorescent pinpoint apple green elementary bodies (EBs). However, none 
of the slides had EBs -2:. 100. The majority (n=24) of the DIF slides had between 2 15 
EBs, probably reflecting the subclinical nature of urethral infection. This could also be 
the reflection of the asymptomatic nature of chlamydia! urethritis. The 11 specimens 
which showed non specific fluorescence and which were subsequently confirmed to be 
negative when compared to positive control slides illustrates the subjectivity with which 
fluorescence microscopy is fraught and also, the importance of using control slides when 
doing diagnostic immunofluorescence microscopy. These patients were also all negative 
when their urines were tested by the LCR. 
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Urine analysis for the detection of endourethral infection has for the last few years, been 
the focus of the new STD testing strategies. It is felt to be the specimen of choice because 
of the non invasive nature of specimen collection. Testing of both male and female FVU 
specimens for C. trachomatis, has been recently evaluated using LCR (Chernesky et al, 
1994a, 1994b; Schachter et al, 1994; Bassiri et al, 1995; Lee et al, 1995). LCR appears 
to be highly sensitive and specific for the detection of chlamydia! urethritis (Chernesky et 
al, 1994a, 1994b). FVU contains exfoliated urethral epithelial cells and is therefore, a 
good diagnostic sample for urethritis. The ease of specimen collection and the automated 
test procedure makes this technique user friendly as well as rapid, highly sensitive (87 % 
to 98%) and specific (99.8% to 100%). 
LCR detected 46/247 (18.6%) of the urogenital infections, thus giving a detection rate of 
75. 9 % . To our knowledge, this is the first time that LCR has been used to detect the
presence of chlamydia! infection in urine specimens of patients with genital ulcer diseases. 
Radebe et al (conference proceedings) used LCR to detect C. trachomatis urethral 
infections from male first catch urine. They did not perform LCR for C. trachomatis on 
all the specimens collected (234 men), but tested only the 70 FVU specimens which were 
negative for gonococcal culture. In a study by Dille et al (1993), a dilution panel of C. 
trachomatis serovar L2 prepared from stocks grown in McCoy cells using both LCR and 
specific amplification of the cryptic plasmid DNA by PCR, were able to consistently 
amplify amounts of DNA equivalent to three C. trachomatis EBs. However, Dille's study 
is not comparable as it used a stock strain whereas in this study, patient specimens were 
utilised. 
The number of urethral specimens that were positive by DIF and/or LCR or both totalled 
54/230 (23.5%). DIF as compared to LCR identified 36/54 chlamydia! infections while 
LCR identified 41/54. There were 23 (10.0%) specimens positive by both tests. Overall, 
46/247 FVU specimens were positive by LCR alone. This shows that DIF would have 
been as sensitive as LCR, had it not been for the 17 patients who had phimosis and 
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endourethral swabs could not be collected. The low sensitivity of the DIF and LCR test 
for chlamydia as compared to PCR, may be due to their dependency upon the amount of 
inflammation in the urethra. How this relates to ulcer scrapings is unknown. Since the 
main site of infection was the outer genitalia (penis), there may not have been concurrent 
chlamydia! infection in the urethra or the infection titres were extremely low. These 
results indicate as expected, that FVU cannot be used to diagnose the ulcerative chlamydia! 
disease. 
Four techniques were used to diagnose both LGV and urethral infections. Culture and 
PCR were used for the detection of LGV while DIF and LCR were used for the detection 
of urethritis. Specimens were categorised as positive for genital ulcer or LGV, if they 
were positive by culture and/or PCR, and as positive for urethritis if they were positive 
by DIF and/or LCR. Tissue culture being the "gold standard", detected only 13/247 
(5.3 %) of the specimens tested. Of these, 4 were positive by all tests used viz. culture, 
PCR, LCR, and DIF; 6 by culture, LCR and PCR, and none were negative by PCR, 
LCR, and DIF. Specific amplification of plasmid DNA by PCR of ulcer specimens, was 
found to be the most sensitive method detecting 55/247 (22. 3 % ) of the infections for all 
categories analyzed, with LCR [detecting 46/247 (18.6%) infections] and DIF [detecting 
36/230 (15.6%) infections] being less sensitive. 
Of the 24 7 patients enrolled in the study, C. trachomatis was not detected in urethral 
specimens (n = 193) by both DIF and LCR. From these 193, 16.1 % had C. trachomatis 
isolated from their ulcer specimens. Of the 54 that had chlamydia! urethritis (i .e from 
whose endourethral specimens C. trachomatis was cultured), 44.4% had Chlamydia in 
their ulcer(s). When considering the 55 genital ulcer specimens in which C. trachomatis 
(PCR and/ or culture confirmed) was detected, 24 ( 44 % ) had concurrent urethral 
colonisation, while 31 (56.4%) had no Chlamydia in the urethra. Of the 5 patients with 
proven L strains diagnosed by immunotyping, 2 also had urethritis; 3/4 persons from 
whom non LGV strains were isolated, also had urethritis. Of the 13 specimens from 
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which chlamydia was successfully cultured, 11 had mixed infections i.e with syphilis 
(n=4), chancroid (n=4) and granuloma (n=3). Despite the drawbacks, this data shows 
that genital ulcer infections are underdiagnosed and on the increase. There are two 
possibilities to these concurrent infections; either non LGV strains such as E and Ia, can 
cause genital ulcers or that there could have been contamination of the ulcers by the 
urethral discharge, thereby leading to the isolation of non-LGV strains from ulcers. Since 
PCR is highly sensitive, it would be interesting to know whether specific amplification of 
the endogenous plasmid DNA by PCR reflects only the presence of plasmids of dead 
Chlamydiae or the presence of low copy numbers of still viable chlamydiae. In the case 
of the latter, the patient might still be infectious. Either way, this has to be evaluated 
further. There was a significant association (RR 2.75, p=0.001) in patients with C. 
trachomatis colonising either the urethra or ulcer(s), i.e chlamydia! infection detected in 
the urethra was also likely to be present in ulcers and vice versa. Furthermore, those who 
had chlamydia! urethritis are 2. 75 times more likely to have chlamydia isolated from their 
genital ulcers than those patients who did not have urethritis. 
From the above data, four groups of patients can be identified. The first being those from 
whose ulcer(s), LGV strains (5/9) were isolated; these can be diagnosed as definite LGV. 
The second group includes patients in whom the presence of C. trachomatis was detected 
by PCR in the ulcer(s) but not in the urethra, as well as those, from whose ulcer(s) 
oculogenital strains were isolated; this group can be considered as probable LGV. The 
third group includes patients whose ulcers contained an oculogenital strain and C. 
trachomatis was also detected in the urethra, plus those patients from whose genital ulcer 
specimens C. trachomatis was not detected by PCR but the endourethral specimens were 
positive by DIF and/or LCR; this group can be considered as inconclusive. The fourth 
and last group is the non LGV group, which encompasses all specimens in which C. 
trachomatis was not isolated from the ulcer but in the urethra, and those specimens that 
were negative by all tests. 
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Certain conclusions regarding the epidemiological characteristics, spread and risk factors 
of LGV in Durban, Kwazulu Natal, can be drawn. There is no national data in South 
Africa on the prevalence of chlamydia! diseases especially GUD, because most infections 
are neither revealed nor reported officially. There is a lack of knowledge as far as the 
disease is concerned and a lack of proper diagnostic techniques in various centres and 
chlamydia! treatment in most clinics. It is clear that chlamydia! infections have been 
increasing in the Durban region and transmission has been facilitated by the fact that 
chlamydia! urogenital infections are often asymptomatic. Our data also shows that a more 
relaxed attitude towards sexual activity associated with the low age at first intercourse and 
higher frequency of intercourse allow an increased possibility of infection, which 
contribute to this high frequency of chlamydia positive cases. 
Regular well planned screening programmes of this nature should be continued so that the 
prevalence of chlamydia infection can be monitored and these, can guide management 
policies when it comes to drawing up syndromic management protocols. As far as 
chlamydia! diagnosis of genital ulcers is concerned, plasmid PCR (despite its inability to 
differentiate between the oculogenital and the LGV serotypes) is the method of choice 
above culture alone. However, further investigations of the significance of the 
oculogenital strains in the pathogenesis of ulcer disease are required. 
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APPENDICES: PROTOCOL FOR MEDIA AND REAGENT PREPARATION 
Note: All autoclaving was peiformed at 121°C for 15 min. 
Water used was sterile triple distilled water. 
For sterility checking media was incubated at 37°C in 5% CO2 for 24 hours (h)
APPENDIX 1: MEDIA, ANTIBIOTICS AND SOLUTIONS 
USED FOR CULTURE 
1.1 Reagents obtained from Bio-Whittaker (Durban, South Africa) 
- Minimum Essential Media (MEM) Eagle with Earle's salts (# 12-611)
- MEM Non Essential Amino Acids (NEAA) (# 13-144)
Chlamydia Cycloheximide Overlay Base Media (# 12 712)





The above component was dissolved; 0.6 ml thereof, was aliquoted into 1.5 ml 
cryotubes and stored at -20°C. 0.5 ml/500 ml MEM was used to obtain a final 





The above component was dissolved and 0.6 ml aliquots were dispensed into 
1.5 ml cryotubes and stored at -20°C. 0.5 ml/500 ml MEM was used to get to 






The above component was dissolved and 0.6 ml aliquots were dispensed into 
1.5 ml cryotubes and stored at 20°C. 0.5 ml/500 ml MEM was used to get to 
a final concentration of 10 µglml. 
1.3 Chlamydia Growth/Culture Medium for McCoy Cells 
E MEM with L glutamine
NEAA (100 X) 
10% Foetal calf serum (FCS) 
Gentamicin (10 ,ug/ml) 
Vancomycin (10 ,ug/ml) 







The above components were mixed and filter sterilized. The medium was 
stored at 4°C. 
1.4 Chlamydia Maintenance Medium for McCoy Cells 
E MEM with L-glutamine 500.0 ml 
NEAA (lO0X) 5.0 ml 
FCS (5%) 12.5 ml 
Gentamicin (10 µg/ml) 0.5 ml 
Vancomycin (10 µg/ml) 0.5 ml 
Amphotericin B (5 µg/ml) 1.0 ml 
These components were mixed, filter sterilized and stored at 4°C. 
1.5 Chlamydia Transport Medium (CTM) 
E MEM with L gJutamine
FCS (10 %) 
10 % Glucose 
Gentamicin (10 µ.g/ml) 
Vancomycin (10 µ.g/ml) 








The above components were mixed and filter sterilized. 2 ml aliquots of the 
transport medium were added into cryotubes and stored at 20°C until required. 
1.6 Chlamydia trachomatis monoclonal antibody culture stain 
The lyophilized stain was resuspended with 3.0 ml of diluent provided with the 
kit. The stain was then mixed properly and left to stand at room temperature 
for 15 min prior to use. (Syva # 8H019) 
1. 7 Chlamydia trachomatis monoclonal antibody direct slide stain 
The lyophilized stain was reconstituted with 2.0 ml of diluent provided with the 
kit. The stain was mixed properly and allowed to stand for 15 min prior to use. 
(Syva # 8H139) 
1.8 EDTA Solution (0.02 %) 
1 M EDT A solution (pH 8) 
Phosphate buffered saline (PBS) 
5.0 ml 
88.0 ml 
The components were added into a 100 ml schott bottle, mixed and stored at 
room temperature. 
1.9 Freezing Medium 
Solution 1 = E MEM + 10% FCS 
Solution 2 = Solution 1 + 10% Glycerol 
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To prepare solution 1, 180.0 ml of E-MEM were mixed with 20.0 ml of FCS. 
18 ml aliquots from solution 1 were added to universal bottles and 2.0 ml of 
glycerol were added to each bottle to get solution 2 with a final concentration of 
10% Glycerol. These were stored at 20°C. 





The above components were dissolved and the volume brought up to 100.0 ml 
with E MEM. The solution was filter sterilized using a 0.2 µ,m membrane filter 
and aliquoted into 25.0 ml volumes. These were stored at 4°C. 
1. 11 Disinfectant for hood (METHS) 






This 500.0 ml mixture was prepared in a squeeze bottle and stored in the hood. 
1.12 Phosphate Buffered Saline (PBS) 
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5 PBS tablets were added to each 500 ml sterile Schott bottle. The tablets were 




1.13 0.4 M Sucrose-Phosphate Buffer (4-SP) 
sucrose 
Anhydrous dipotassium hydrogen 
phosphate (K
2HP04) 





The sucrose was dissolved in about 250.0 ml of water and the potassium 
phosphates in about 50.0 ml. The two solutions were mixed in one 500 ml 
measuring cylinder and the volume adjusted to 500.0 ml with water. If 
necessary, the pH was adjusted to 7 .0 with dilute HCl or Na OH solution. 









The above component was dissolved in PBS to prepare a 0.4% stock solution. 
10.0 ml of the stock solution was added into a glass bottle and diluted with 
40.0 ml of PBS. This was stored at 4°C. 
1.15 Trypsin (0.25 %) 
Trypsin (2. 5 % ) 




A bottle of 2.5 % Trypsin (20.0 ml) was thawed, poured into a 75 cm3 culture 
flask, then topped up to 200.0 ml with PBS (180.0 ml). 1.0 ml of the solution 
was added per track vial and stored at 20°C. 
APPENDIX 2: MEDIA AND SOLUTIONS USED FOR 
MICROIMMUNOFLUORESCENCE (MIF) TYPING 
2.1 Antibiotics [Nystatin, Gentamycin, and Vancomycin (NGV-stock solutions)] 
Nystatin 
8 bottles (20 ml each), 10.000 Units (U)/ml 
Total volume required: 160 ml = 1.600.000 U 
Gentamycin 
8 vials (2 ml each), 40 mg/ml 
Total volume required: 16 ml = (640 mg) 
Vancomycin 
2 vials (10 ml each), 1 g/vial 
Total volume required: 16 ml = 1600 mg 
8 bottles of Nystatin (20 ml each) were dispensed into a 250 ml Erlenmeyer 
flask. A sterile magnet was placed inside the flask which was in turn, placed on 
a magnetic stirrer. The flask was covered with foil at all times. 
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Metal caps were removed from each Gentamycin vial which were first swabbed 
with ethanol soaked gauze and then flamed. 2 ml of Gentamicin were drawn 
into a 5 ml syringe and then added to the flask. 
Metal caps were removed from each Vancomycin vial which were first swabbed 
with ethanol soaked gauze and then flamed. 5 ml of tdH20 were drawn, and 
using a syringe, the water was injected into the vial for resuspension. The 
solution was well mixed, and 4 ml of the resuspended Vancomycin was drawn 
and added to the Erlemeyer flask. The whole procedure was repeated with all 
the vials. 3.2 ml of NGV stock solution were aliquoted into sterile track vials, 
and stored at 20°C until required. 
2.2 APMEM: Autoclavable powdered Minimal Essential Medium with glucose 
added 
APMEM (SIGMA # M0769) 





APMEM and glucose were dissolved in distilled water using a magnetic stirrer. 
420.0 ml of media were aliquoted per 500 ml serum bottle, then autoclaved at 
121 °c for 30 min. Media was stored at 4°C. 
2.3 Bovine Serum Albumin (BSA) Stock, 10 mg/ml 
BSA 




The above components were mixed thoroughly (without heating) on a magnetic 
stirrer until dissolved. The reagent was filter sterilized through a 0.2 micron 
nalgene disposable filter unit; 0. 8 ml aliquots were dispensed into cryotubes and 
stored at 20°C for less than 6 months. 
2.4 CMGH (Chlamydia - Complete Media with glucose plus HEPES) pH 7.5 
GAPMEM 
Foetal Bovine serum 
HEPES (1 M) 






Foetal bovine serum, HEPES and sodium bicarhonate were added to GAPMEM, 
mixed well and the pH adjusted to 7.5 using lON NaOH. The CMGH was 
incubated at 35°C for 7 days to check for sterility. The bottles were then, 
transferred to 4°C refrigerator. 
Prior to use: 5.0 ml of L glutamine, cycloheximide and NGV (Amphotericin B, 
Gentamicin, Vancomycin) were added to the CMGH. 
2.5 Chlamydia group specific, monoclonal antibody culture stain [CF-2] 
Dilution 1:40 (8ml} 1:50 (8ml} 1 :60 (8ml} 
CF2 stock 200.0 µ1 160.0 ml 135.0 ml 
BSA (stock) 0.8 ml 0.8 ml 0.8 ml 
PBS + Evans blue 7.0 ml 7.0 ml 7.1 ml 
+ sodium azide
+ glycerol stock
All ingredients were mixed into the BSA amber 2 dram vial, then vortexed. 
The stain was stored at 4°C. 
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Warning: Evans blue is an animal carcinogen; mask and gloves were worn and 
appropriate precautions taken. 





Cycloheximide (Sigma # C 6255) was dissolved in water in an erlenmeyer flask 
on a magnetic stirrer. The mixture was then filter sterilized through a 0.22 µm 
filter and 1 ml aliquots dispensed into cryotubes and stored at 70°C. 
2. 7 HEPES Buffer (1 M, pH 7 .5) 
HEPES 
water 
NaOH (10 N) 
714.9 g 
3.0 L 
HEPES (Sigma #H9136) was added to water on a magnetic stirrer to dissolve. 
The solution was refrigerated overnight to equilibrate. The pH was adjusted to 
7 .5 using ION Na OH and then filter sterilized through a 22.0 µm membrane 
filter. The filter flasks containing the solutions were incubated for 1 week to 
check for contamination. 150 ml aliquots were dispensed into 200 ml bottles 
and stored at room temperature. 
2.8 Monoclonal Antibody Blocking Solution 
BSA 
NaN3 (sodium azide) 
Tween-20 
(Polyoxyethylene Sorbitan Monolaurate) 





The above components were mixed thoroughly on a magnetic stirrer (without 
heating) until dissolved. The solution was then filter sterilized into 250 ml 
schott bottles using a 0.2 micron nalgene disposable filter unit. The solution 
was stored at 4°C for 6 months. 
2.9 PBS/Evans Blue/Sodium Azide diluent for monoclonal antibody stain 
(25 X EB stock) 
PBS (pH 7.6) 
evans blue (0.5 %) 




The above components were dissolved thoroughly on a magnetic stirrer by 
applying very low heat. The stain was filter sterilized using a 0.2 micron 
nalgene disposable filter unit and then stored at room temperature. 
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2.10 PBS/Evans Blue/Sodium Azide diluent for monoclonal antibody stain 
(1 X stock) 
PBS (pH 7.6) 
glycerol 




Glycerol and 25X Evanss Blue (EB) stock were mixed into PBS and stored at 
room temperature for no more than six months. 
2.11 PBS, pH 7.4 (0.05 % Tween) (1 X) 





The above components were mixed and stored at room temperature. PBS T was 
added to the label. 
2.12 Sucrose-Phosphate-Glutamate Freezing Media (SPG) 
Sucrose 75.00 g 
KH2PO4 0.52 g 
Na2HPO4 . 7H2O 2.30 g 
Glutamic acid 0.72 g 
water to 1.00 L 
The above components were combined together with 800.0 ml of water, and 
mixed thoroughly on a magnetic stirrer. The pH was adjusted to 7.5 using 
10 M NaOH or HCl as required. The volume was then adjusted to 1000.0 ml. 
The solution was filter sterilized using a 22.0 micron filter and stored at 4°C for 
� 12 months. 
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APPENDIX 3: SOLUTIONS USED FOR DNA EXTRACTION 
3.1 Absolute Ethanol cold 
50.0 ml of absolute ethanol (BDH) was poured into a 50 ml plastic tube and 
stored at 20°C. 
3.2 Chloroform-isoamyl alcohol (24:1) 
24 parts of CHC13 were mixed with 1 part of isoamyl alcohol in a dark bottle. 
The bottle was then stored at 4°C. 
3.3 Cold Ethanol (70 %) 
70.0 ml of absolute ethanol and 30 ml of water were added, mixed and stored at 
20°C in a plastic bottle.





To prepare a 10 mg/ml stock solution, the above component was dissolved in 
20.0 ml of water and stirred on a magnetic stirrer for several hours to ensure 
that the dye had dissolved. The container was wrapped in foil and stored at 
4°C. For every 100.0 ml of agar, 100.0 µ1 of ethidium bromide solution were
added i.e 1.0 µI/ml. 






The above component was dissolved in 200.0 ml of water by stirring vigorously 
on a magnetic stirrer. The pH was adjusted with approximately 10.0 g of 
NaOH pellets and the volume adjusted to 250.0 ml with water. The solution 
was autoclaved and stored at room temperature. 
3.6 0.5 M EDTA (pH 8) 
disodium EDTA.2H20 (Sigma# ED255) 46.53 g 
( d isodium ethy lened iaminetetraacetate. 2H20) 
The above reagent was dissolved in 200.0 ml of water by stirring vigorously on 
a magnetic stirrer. The pH was adjusted to 8 with approximately 6.0 g of 
NaOH pellets. The volume was adjusted to 250.0 ml with water, then aliquoted 
in 20 ml amounts, autoclaved and stored at room temperature. 
3. 7 1 M Hydrochloric Acid (HCI) 
20.0 ml of concentrated HCl was diluted in 220.0 ml of water. The solution 
was stored at room temperature, in a dark bottle. 
3.8 5 M NaCl 




The solution was heated at low temperature while stirring to dissolve the 
chemical. The volume was adjusted to 250.0 ml with water, dispensed into 
20 ml aliquots, autoclaved, and stored at room temperature.
3.9 Phenol/Chloroform/iso-amyl alcohol (25:24:1) 
25 parts of phenol and 24 parts of CHCl3 were mixed with 1 part of iso amyl 
alcohol in a dark bottle. The bottle was then stored at 4°C. 
3.10 Proteinase K (Boehringer Mannheim) 
To prepare a stock solution of 20 mg/ml, 100 mg were weighed out into a 
sterile bijou bottle and dissolved in 5 ml of water. 250 µI aliquots were 
dispensed into 0.5 ml Eppendorf tubes and stored at 20°C. 
3.11 RNAse stock solution (10 mg/ml) 
pancreatic RNAse 
sodium acetate (0.01 M) 
0.2 g 
20.0 ml 
The pancreatic RNAse was dissolved in 20.0 ml of sodium acetate solution 
(pH 5.2) and boiled at 100°C for 15 min. The solution was allowed to cool 
slowly to room temperature, then the pH was adjusted to 7.4 by adding 0.1 
volumes of 1 M Tris.HCI. The solution was dispensed into 2 ml aliquots and 
stored at 20°C. 
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The above component was dissolved in water and the pH adjusted to 5.2 with 
glacial acetic acid or adjusted to pH 7.0 with dilute acetic acid. The volume 
was adjusted to 250.0 ml with water,dispensed into 20 ml aliquots, autoclaved 
and stored at room temperature. 
3.13 Sodium dodecyl sulphate 10% (SDS) 
SDS 




SDS was dissolved in 200.0 ml of water and the final volume was adjusted to 
250.0 ml. The solution was dispensed into aliquots and stored at room 
temperature. 
NB! The solution was not autoclaved nor was the pH adjusted. 
3.14 10 X Tris-EDTA (TE) Buffer (pH 8.0) 
1 M Tris HCl (pH 8.0) 
0.5 M EDTA (pH 8.0) 
water 




3.15 0.1 X TE Buffer 




The buffer was stored at room temperature. 
3.16 1 M Tris-HCI (pH 8) 




The above component was dissolved in 200.0 ml of water. The pH was 
adjusted to 8 by adding approximately 10.0 ml (drop by drop) of com.:entrated 
HCl, thereafter, the volume was brought up to 250.0 ml. The solution was 
aliquoted into working solutions, autoclaved and store at room temperature. 
3.17 2 M Tris-HCI (pH 9.0) 





The above component was dissolved in 200.0 ml of water. The pH was 
adjusted to 9.0 by adding approximately 10.0 ml (drop by drop) of concentrated 
HCl, thereafter, the volume was brought up to 250.0 ml. The solution was 
aliquoted into working solutions, autoclaved and stored at room temperature. 
II APPENDIX 4: REAGENTS USED FOR PCR 
4.1 Deoxynucleoside Triphosphate (dNTP) Mix 
dATP (10 mM) 25.0 µl 
dCTP (10 mM) 25.0 µl 
dGTP (10 mM) 25.0 µl 
dTTP (10 mM) 25.0 µl 
Filtered water 100.0 µI 
The above components were added into a 1.5 ml sterile Eppendorf tube, 
vortexed and stored at 20°C. 
4.2 10 X PCR Buffer 
1 M Tris HCI (100 mM), pH 8.0 
1 M KCI (500 mM) 







The above components were mixed, aliquoted into 2.0 ml Eppendorf tubes and 
stored at 20°C. 
4.3 Reagents obtained from University of Washington Chemistry Lab. 
- 10 X magnesium chloride (MgCl2) 1. 75 mM for plasmid PCR
10 X MgC12 100 mM for MOMP PCR
Primers (Plasmid): ODnaB L (20 µM)
ODnaB R (20 µM) 
Primers (MOMP): oDVD IV (20 µM)
o5'MOMP (20 µM) 
11 
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APPENDIX 5: REAGENTS AND BUFFERS USED IN ELECTROPHORESIS 
5.1 Acrylamide 30% 
Acrylamide 





The solution was heated to 37°C to dissolve the chemicals. The solution was 
adjusted to 100.0 ml with water and filter sterilized through a Nalgene filter 
(0.45 micron pore size). The pH was checked to make certain that it was 7.0 
or less, and the solution was stored at room temperature in dark bottles. 





This solution was stored at 4°C for several weeks. 
5.3 6 X Gel-loading Buffer 
bromophenol blue 
xylene cyanol FF 




The above components were mixed and stored at 4°C. 
Bromophenol blue migrates through agarose gels approximately 2.2 fold faster
than xylene cyanol FF, independent of the agarose concentration.
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This gel-loading buff er serves three purposes: 
- it increases the density of the sample, ensuring that the DNA drops evenly
into the well,
- it adds colour to the sample, thereby simplifying the loading process, and
- it contains dyes that, in an electric field, move toward the anode at
predictable rates.
5.4 Molecular Size Markers 
1 kbp (GIBCO BRL)
Marker II (Boehringer) 
Marker V (Boehringer) 
Marker VI (Boehringer) 
Marker IX (Boehringer) 
These were all stored in the 20°C freezer. 
5.5 Restriction enzymes (Boehringer Mannheim) 
Alu I (# 239 275) 
Cfo I (# 688 541) 
Dde I (# 835 293) 
EcoRI (# 703 737) 
Fok I (# 1004 824) 
Hinfl (# 779 652) 
These were all stored in the 20°C freezer. 
5.6 5 X TBE buffer (Tris-borate-EDTA) 
tris base 
boric acid 






The solution was diluted to working concentration with water and stored at 
room temperature. 
5.7 1 X TBE Buffer 





A 1 :5 (50.0 ml 5X TBE buffer + 200.0 ml water) dilution was prepared. The 
solution was stored at room temperature. 
5.8 0.5 X TBE buffer 




The buffer solution was mixed and stored at room temperature. 
APPENDIX 6: GENITAL ULCER STUDY QUESTIONNAIRE 
GENITAL ULCER STUDY 1995 
1. STUDY NO
2. NAME CLINIC NO 
3. AGE IN YEARS
4. MARITAL STATUS SINGLE =1 
MARRIED =2 
ST ABLE PARTNER =3 
5. CIRCUMCISED YES =1 
NO =2 
6. SEXUAL HISTORY
A. AGE AT FIRST INTERCOURSE
----
B. NO. OF SEXUAL PARTNERS (SINCE JANUARY 1995) ___ 
C. TOTAL NO. OF LIFETIME PARTNERS
----
D. PREVIOUS EPISODES OF STD
----
E. LAST SEXUAL CONTACT (DAYS) ___ _
F. DURATION OF LESION
----
G. INTERCOURSE WHILE LESION PRESENT ___ _
7.LYMPHADENOPATHY YES =1 
NO =2 























9. NO. OF LESIONS
----














































15. CONCURRENT URETHRAL DISCHARGE:
YES 
NO 
16. CLINICAL DIAGNOSIS:
PRIMARY SYPHILIS 
SECONDARY SYPHILIS 
CHANCROID 
LGV 
HERPES GENITALIS 
GRANULOMA INGUINALE 
WARTS 
OTHER 
17. TREATMENT: PENICILLIN
ERYTHROMYCIN 
TETRACYCLINE 
CEFTRIAXONE 
OFLOXACIN 
CO TRIMOXAZOLE 
ACYCLOVIR 
BACTRIM 
OTHER 
=1 
=2 
=3 
=4 
=5 
=6 
=1 
=2 
=l 
=2 
=1 
=2 
=3 
=4 
=5 
=6 
=7 
=8 
=1 
=2 
=3 
=4 
=5 
=6 
=7 
=8 
=9 
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